Statutory Rules 1986 No. 1941
National Health (Pharmaceutical Benefits)
Regulations2 (Amendment)
WHEREAS it is provided by sub-section 101 (4) of the National Health Act 1953 that a drug or medicinal preparation that was not a pharmaceutical benefit under that Act immediately before the commencement of that subsection shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:
AND WHEREAS the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that each of the following drugs or medicinal preparations be prescribed as a pharmaceutical benefit under section 85 of that Act, namely:
(a) Diltiazem Hydrochloride;
(b) Domperidone;
(c) Enalapril Maleate;
(d) Flecainide Acetate;
(e) Insulin, Human (Synthetic);
(f) Insulin Isophane, Human (Synthetic);
(g) Leuprorelin Acetate;
(h) Misoprostol;
(i) Potassium Clavulanate; and
(j) Probucol:
AND WHEREAS it is desirable, amongst other things, to prescribe each of those drugs or medicinal preparations as a pharmaceutical benefit under that section:
NOW THEREFORE I, the Governor-General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953.
Dated 30 July 1986.
N. M. STEPHEN
Governor-General
By His Excellency’s Command,
Neal Blewett
Minister of State for Health
(S.R. 198/86) 10/25.7.1986
Commencement
1. These Regulations shall come into operation on 1 August 1986.
Schedules 1, 2, 3, 4 and 5
2. Schedules 1, 2, 3, 4 and 5 to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules substituted:
SCHEDULE 1 Sub-regulations 10 (1) and (2)
DRUGS AND MEDICINAL PREPARATIONS IN THE BRITISH PHARMACOPOEIA THAT ARE NOT TO BE SUPPLIED AS OR, EXCEPT AS SPECIALLY PROVIDED, USED IN PHARMACEUTICAL BENEFITS
1 | Acetarsol | 49 | Ammonium Chloride Mixture |
2 | Acetarsol Pessaries | 50 | Ammonium Chloride and Morphine Mixture |
3 | Acetic Acid, Glacial |
|
|
4 | Acetone | 51 | Amodiaquine Hydrochloride |
5 | Adrenaline Acid Tartrate | 52 | Amodiaquine Tablets |
6 | Adrenaline and Atropine Spray, Compound | 53 | Amphetamine Sulphate |
|
| 54 | Ampicillin |
7 | Adrenaline Solution | 55 | Ampicillin Tablets, Paediatric |
8 | Ajmaline | 56 | Amylmetacresol |
9 | Ajmaline Monoethanolate | 57 | Amylobarbitone |
10 | Albumin | 58 | Amylobarbitone Sodium Capsules |
11 | Albumin, Dried | 59 | Amylobarbitone Sodium Tablets |
12 | Alclofenac | 60 | Amylobarbitone Tablets |
13 | Alclofenac Capsules | 61 | Ancrod Injection |
14 | Almond Oil | 62 | Aniseed |
15 | Aloes | 63 | Anise Oil |
16 | Aloin | 64 | Anise Water, Concentrated |
17 | Aloxiprin | 65 | Anticoagulant and Preservative Solutions for Blood |
18 | Alphadolone Acetate |
|
|
19 | Alpha Tocopheryl Acetate | 66 | Anti-D (Rh0) Immunoglobulin Injection |
20 | Alphaxalone |
|
|
21 | Alprenolol Hydrochloride | 67 | Antimony Sodium Tartrate |
22 | Alprenolol Injection | 68 | Antimony Sodium Tartrate Injection |
23 | Aluminium Acetate Ear Drops | 69 | Antitetanus Immunoglobulin Injection |
24 | Aluminium Glycinate | 70 | Antivaccinia Immunoglobulin |
25 | Aluminium Hydroxide Tablets |
| Injection |
26 | Aluminium Magnesium Silicate | 71 | Apomorphine Hydrochloride |
27 | Aluminium Paste, Compound | 72 | Arachis Oil |
28 | Aluminium Phosphate, Dried | 73 | Aspirin and Caffeine Tablets |
29 | Aluminium Phosphate Mixture | 74 | Aspirin and Codeine Tablets |
30 | Aluminium Phosphate Tablets | 75 | Aspirin and Codeine Tablets, Dispersible |
31 | Aluminium Powder |
|
|
32 | Aluminium Sulphate | 76 | Aspirin Tablets, Paediatric Dispersible |
33 | Amaranth Solution | 77 | Atropine Eye Drops |
34 | Amethocaine Eye Drops | 78 | Atropine Methobromide |
35 | Amethocaine Hydrochloride | 79 | Attapulgite |
36 | Aminobenzoic Acid | 80 | Attapulgite, Activated |
37 | Aminobenzoic Acid Lotion | 81 | Azathioprine |
38 | Aminocaproic Acid Oral Effervescent Powder | 82 | Bandage, Calico, Triangular |
|
| 83 | Bandage, Cotton and Rubber Elastic |
39 | Aminophylline Suppositories | 84 | Bandage, Cotton Conforming |
40 | Amitriptyline Embonate | 85 | Bandage, Cotton Crepe |
41 | Amitriptyline Embonate Mixture | 86 | Bandage, Cotton Stretch |
42 | Amitriptyline Hydrochloride | 87 | Bandage, Crepe |
43 | Ammonia and Ipecacuanha Mixture | 88 | Bandage, Domette |
44 | Ammonia Solution, Aromatic | 89 | Bandage, Elastic Adhesive |
45 | Ammonia Solution, Dilute | 90 | Bandage, Elastic Adhesive, Half-spread |
46 | Ammonia Solution, Strong |
|
|
47 | Ammonium Acetate Solution, Strong | 91 | Bandage, Elastic Adhesive, Ventilated |
48 | Ammonium Bicarbonate | 92 | Bandage, Elastic Web |
SCHEDULE 1—continued
93 | Bandage, Heavy Cotton and Rubber Elastic | 147 | Boric Acid |
|
| 148 | Brilliant Green |
94 | Bandage, Open Wove | 149 | Brilliant Green and Crystal Violet Paint |
95 | Bandage, Plaster of Paris |
|
|
96 | Bandage, Titanium Dioxide Elastic Adhesive | 150 | Bromhexine Hydrochloride |
|
| 151 | Bromhexine Hydrochloride Tablets |
97 | Bandage, Zinc Paste | 152 | Bupivacaine and Adrenaline Injection |
98 | Bandage, Zinc Paste and Coal Tar | 153 | Bupivacaine Hydrochloride |
99 | Bandage, Zinc Paste and Ichthammol | 154 | Bupivacaine Hydrochloride Injection |
100 | Bandage, Zinc Paste, Calamine and Clioquinol | 155 | Busulphan |
|
| 156 | Butobarbitone |
101 | Barium Sulphate | 157 | Butobarbitone Tablets |
102 | Barium Sulphate for Suspension | 158 | Butylated Hydroxyanisole |
103 | Barium Sulphate Suspension | 159 | Butylated Hydroxytoluene |
104 | Beclomethasone Dipropionate Cream | 160 | Butyl Hydroxybenzoate |
105 | Beclomethasone Dipropionate Ointment | 161 | Caffeine Hydrate |
|
| 162 | Calamine and Coal Tar Ointment |
106 | Beeswax, Yellow | 163 | Calciferol Injection |
107 | Belladonna Dry Extract | 164 | Calciferol Solution |
108 | Belladonna Herb | 165 | Calcium Acetate |
109 | Belladonna Herb, Prepared | 166 | Calcium Gluconate |
110 | Bendrofluazide | 167 | Calcium Gluconate Injection |
111 | Benorylate | 168 | Calcium Gluconate Tablets |
112 | Benorylate Mixture | 169 | Calcium Gluconate Tablets, Effervescent |
113 | Benorylate Tablets |
|
|
114 | Benzaldehyde | 170 | Calcium Hydrogen Phosphate |
115 | Benzaldehyde Spirit | 171 | Calcium Lactate |
116 | Benzalkonium Chloride Solution | 172 | Calcium Lactate Tablets |
117 | Benzhexol Hydrochloride | 173 | Calcium Phosphate |
118 | Benzoin Inhalation | 174 | Calcium Sodium Lactate |
119 | Benzoin, Siam | 175 | Calcium Sulphate, Dried |
120 | Benzoin, Sumatra | 176 | Calico, Unbleached |
121 | Benztropine Mesylate | 177 | Camphor |
122 | Benzyl Alcohol | 178 | Camphorated Opium Tincture |
123 | Benzyl Hydroxybenzoate | 179 | Camphorated Opium Tincture, Concentrated |
124 | Benzylpenicillin Sodium |
|
|
125 | Benzylpenicillin Tablets | 180 | Camphor Water, Concentrated |
126 | Bephenium Hydroxynaphthoate | 181 | Candicidin |
127 | Bephenium Hydroxynaphthoate Granules | 182 | Capreomycin Injection |
|
| 183 | Capreomycin Sulphate |
128 | Betamethasone | 184 | Caraway |
129 | Betamethasone Sodium Phosphate Injection | 185 | Caraway Oil |
|
| 186 | Carbenoxolone Sodium |
130 | Betamethasone Sodium Phosphate Tablets | 187 | Carbenoxolone Tablets |
|
| 188 | Carbidopa |
131 | Betamethasone Valerate Lotion | 189 | Carbimazole |
132 | Betamethasone Valerate Scalp Application | 190 | Carbomer |
|
| 191 | Carbon Dioxide |
133 | Bethanidine Sulphate | 192 | Carbromal |
134 | Bethanidine Tablets | 193 | Cardamom Fruit |
135 | Biperiden | 194 | Cardamom Oil |
136 | Bismuth Lozenges, Compound | 195 | Cardamom Tincture, Aromatic |
137 | Bismuth Oral Powder, Compound | 196 | Cardamom Tincture, Compound |
138 | Bismuth Subcarbonate | 197 | Carnauba Wax |
139 | Bismuth Subgallate | 198 | Cascara |
140 | Bismuth Subgallate Suppositories | 199 | Cascara Dry Extract |
141 | Bismuth Subgallate Suppositories, Compound | 200 | Cascara Elixir |
|
| 201 | Cascara Liquid Extract |
142 | Black Currant | 202 | Cascara Tablets |
143 | Black Currant Syrup | 203 | Castor Oil |
144 | Blood, Plasma-reduced | 204 | Catechu |
145 | Blood, Whole | 205 | Catechu Tincture |
146 | Borax | 206 | Catgut, Sterile |
SCHEDULE 1—continued
207 | Cellacephate | 268 | Cinnamon Oil |
208 | Cellulose, Dispersible | 269 | Cinnamon Water, Concentrated |
209 | Cellulose, Microcrystalline | 270 | Clindamycin Hydrochloride |
210 | Cellulose, Oxidised | 271 | Clofazimine |
211 | Cephalexin Tablets | 272 | Clofazimine Capsules |
212 | Cephaloridine | 273 | Clofibrate |
213 | Cephaloridine Injection | 274 | Clomiphene Citrate |
214 | Cephradine | 275 | Clomipramine Hydrochloride Capsules |
215 | Cephradine Capsules | 276 | Clonidine Hydrochloride |
216 | Cetomacrogol 1000 | 277 | Clove |
217 | Cetrimide Solution | 278 | Clove Oil |
218 | Cetrimide Solution, Strong | 279 | Coal Tar and Salicylic Acid Ointment |
219 | Cetylpyridinium Chloride | 280 | Coal Tar and Zinc Ointment |
220 | Chalk | 281 | Coal Tar Paste |
221 | Chalk Mixture, Paediatric | 282 | Coal Tar Solution, Strong |
222 | Chalk with Opium Mixture, Aromatic | 283 | Cocaine |
223 | Chamomile Flowers | 284 | Cochineal |
224 | Chloral Elixir, Paediatric | 285 | Cocillana |
225 | Chloral Mixture | 286 | Codeine |
226 | Chlorambucil | 287 | Codeine Linctus |
227 | Chloramphenicol Ear Drops | 288 | Co-dergocrine Mesylate |
228 | Chloramphenicol Palmitate | 289 | Co-dergocrine Mesylate Tablets |
229 | Chlorbutol, Anhydrous | 290 | Cod-liver Oil |
230 | Chlorcyclizine Hydrochloride | 291 | Colchicine |
231 | Chlordiazepoxide | 292 | Colistin Tablets |
232 | Chlordiazepoxide Capsules | 293 | Colophony |
233 | Chlordiazepoxide Hydrochloride | 294 | Concentrated Red Blood Cells |
234 | Chlordiazepoxide Hydrochloride Tablets | 295 | Coriander |
|
| 296 | Coriander Oil |
235 | Chlordiazepoxide Tablets | 297 | Corticotrophin |
236 | Chlorhexidine Acetate | 298 | Corticotrophin Gelatin Injection |
237 | Chlorhexidine Dusting Powder | 299 | Corticotrophin Injection |
238 | Chlorhexidine Gluconate Solution | 300 | Corticotrophin Zinc Injection |
239 | Chlorhexidine Hydrochloride | 301 | Cortisone Acetate |
240 | Chlormethiazole | 302 | Cortisone Injection |
241 | Chloroform | 303 | Co-trimoxazole Intravenous Infusion |
242 | Chloroform and Morphine Tincture | 304 | Co-trimoxazole Mixture |
243 | Chloroquine Phosphate | 305 | Co-trimoxazole Tablets, Dispersible |
244 | Chloroquine Phosphate Injection | 306 | Co-trimoxazole Tablets, Paediatric |
245 | Chloroquine Sulphate Tablets | 307 | Cotton, Absorbent |
246 | Chlorothiazide | 308 | Cresol |
247 | Chlorotrianisene | 309 | Crotamiton |
248 | Chlorotrianisene Capsules | 310 | Crystal Violet Pessaries |
249 | Chlorotrianisene Tablets | 311 | Cyanocobalamin |
250 | Chloroxylenol | 312 | Cyanocobalamin (57Co) Solution |
251 | Chloroxylenol Solution | 313 | Cyanocobalamin (58Co) Solution |
252 | Chlorpheniramine Elixir | 314 | Cyclizine |
253 | Chlorpheniramine Injection | 315 | Cyclizine Lactate Injection |
254 | Chlorpheniramine Maleate | 316 | Cyclizine Tablets |
255 | Chlorpromazine | 317 | Cyclobarbitone Calcium |
256 | Chlorpromazine Hydrochloride | 318 | Cyclomethycaine Sulphate |
257 | Chlorpropamide | 319 | Cyclopenthiazide |
258 | Chlortetracycline Capsules | 320 | Cyclopentolate Eye Drops |
259 | Chlortetracycline Hydrochloride Eye Ointment | 321 | Cyclopentolate Hydrochloride |
|
| 322 | Cyclopropane |
260 | Chlorthalidone | 323 | Cycloserine |
261 | Cholecalciferol | 324 | Cycloserine Capsules |
262 | Choline Theophyllinate Tablets | 325 | Cycloserine Tablets |
263 | Chymotrypsin | 326 | Cyproheptadine Hydrochloride |
264 | Cinchocaine Hydrochloride | 327 | Danthron |
265 | Cinchona Bark | 328 | Debrisoquine Sulphate |
266 | Cinnamic Acid | 329 | Demeclocycline Hydrochloride |
267 | Cinnamon | 330 | Deoxycortone Acetate |
SCHEDULE 1—continued
331 | Deoxycortone Acetate Implants | 394 | Diphtheria and Tetanus Vaccine |
332 | Deoxycortone Acetate Injection | 395 | Diphtheria, Tetanus and Pertussis Vaccine |
333 | Dequalinium Chloride |
|
|
334 | Desferrioxamine Injection | 396 | Diphtheria, Tetanus and Poliomyelitis Vaccine |
335 | Desferrioxamine Mesylate |
|
|
336 | Desipramine Hydrochloride | 397 | Diphtheria Vaccine |
337 | Deslanoside | 398 | Dipipanone Hydrochloride |
338 | Deslanoside Injection | 399 | Dipipanone Hydrochloride and Cyclizine Hydrochloride Tablets |
339 | Dexamphetamine Sulphate |
|
|
340 | Dextran 110 Intravenous Infusion | 400 | Dipipanone Injection |
341 | Dextrin | 401 | Diprophylline |
342 | Dextromethorphan Hydrobromide | 402 | Dipyridamole |
343 | Dextromoramide Tartrate Injection | 403 | Disodium Edetate |
344 | Dextropropoxyphene Capsules | 404 | Disopyramide |
345 | Dextropropoxyphene Hydrochloride | 405 | Disopyramide Phosphate |
346 | Dextropropoxyphene Napsylate | 406 | Disulfiram |
347 | Diamorphine Hydrochloride | 407 | Disulfiram Tablets |
348 | Diamorphine Injection | 408 | Dodecyl Gallate |
349 | Diazepam Capsules | 409 | Domiphen Bromide |
350 | Diazoxide | 410 | Dothiepin Hydrochloride |
351 | Diazoxide Tablets | 411 | Dressing, Chlorhexidine Acetate Gauze |
352 | Dibromopropamidine Isethionate |
|
|
353 | Dichloralphenazone | 412 | Dressing, Elastic Adhesive |
354 | Dichloralphenazone Elixir | 413 | Dressing, Framycetin Sulphate Gauze |
355 | Dichloralphenazone Tablets | 414 | Dressing, Paraffin Gauze |
356 | Dichlorodifluoromethane | 415 | Drostanolone Propionate |
357 | Dichlorophen | 416 | Drostanolone Propionate Injection |
358 | Dichlorophen Tablets | 417 | Dydrogesterone |
359 | Dichlorotetrafluoroethane | 418 | Edrophonium Chloride |
360 | Dichlorphenamide | 419 | Edrophonium Injection |
361 | Dicyclomine Elixir | 420 | Emetine Hydrochloride |
362 | Dicyclomine Hydrochloride | 421 | Emetine Injection |
363 | Dicyclomine Tablets | 422 | Ephedrine |
364 | Dienoestrol Tablets | 423 | Ephedrine, Anhydrous |
365 | Diethlamine Salicylate | 424 | Ephedrine Hydrochloride Elixir |
366 | Diethlamine Salicylate Cream | 425 | Ephedrine Hydrochloride Tablets |
367 | Diethylcarbamazine Citrate | 426 | Ergometrine Maleate |
368 | Diethylcarbamazine Tablets | 427 | Ergotamine Injection |
369 | Diethyl Phthalate | 428 | Erythromycin Estolate Capsules |
370 | Diethylpropion Hydrochloride | 429 | Etamiphylline Camsylate |
371 | Diethyltoluamide | 430 | Etamiphylline Camsylate Injection |
372 | Diflunisal | 431 | Etamiphylline Camsylate Suppositories |
373 | Digitalis Leaf | 432 | Etamiphylline Camsylate Tablets |
374 | Digitalis, Prepared | 433 | Ethacrynic Acid |
375 | Digitalis Tablets, Prepared | 434 | Ethambutol Hydrochloride |
376 | Digitoxin | 435 | Ethambutol Tablets |
377 | Digitoxin Tablets | 436 | Ethamivan |
378 | Digoxin | 437 | Ethamivan Solution |
379 | Digoxin Paediatric Injection | 438 | Ethanol (96 per cent) |
380 | Dihydrocodeine Injection | 439 | Ethanolamine |
381 | Dihydrocodeine Tablets | 440 | Ethanols, Dilute |
382 | Dihydroergotamine Mesylate Injection | 441 | Ether, Anaesthetic |
383 | Dihydroergotamine Mesylate Solution | 442 | Ether, Solvent |
384 | Dihydroergotamine Mesylate Tablets | 443 | Ethionamide |
385 | Dihydroergotamine Tartrate | 444 | Ethionamide Tablets |
386 | Dill Oil | 445 | Ethisterone |
387 | Diloxanide Furoate | 446 | Ethisterone Tablets |
388 | Dimenhydrinate | 447 | Ethosuximide |
389 | Dimenhydrinate Injection | 448 | Ethyl Chloride |
390 | Dimenhydrinate Tablets | 449 | Ethyl Cinnamate |
391 | Dimercaprol | 450 | Ethylenediamine |
392 | Dimethyl Phthalate | 451 | Ethylenediamine Hydrate |
393 | Dimethyl Sulphoxide | 452 | Ethyl Gallate |
SCHEDULE 1—continued
453 | Ethyl Hydroxybenzoate | 514 | Gas Gangrene Antitoxin (Septicum) |
454 | Ethylmorphine Hydrochloride | 515 | Gauze, Absorbent Cotton |
455 | Ethyloestrenol | 516 | Gauze, Absorbent Cotton and Viscose |
456 | Ethyl Oleate | 517 | Gauze, Absorbent Cotton and Viscose Ribbon |
457 | Etofylline |
|
|
458 | Eucalyptus Oil | 518 | Gauze, Absorbent Cotton Ribbon |
459 | Eugenol | 519 | Gauze, Pledget |
460 | Eye Ointment, Simple | 520 | Gauze, Pledget, X-Ray-Detectable |
461 | Eye Pad, Cotton | 521 | Gauze, Swab |
462 | Factor VIII Fraction, Dried | 522 | Gauze, Swab, Filmated |
463 | Factor IX Fraction, Dried | 523 | Gauze, Swab, X-Ray-Detectable |
464 | Fat, Hard | 524 | Gauze, X-Ray-Detectable Absorbent Cotton |
465 | Fenfluramine Hydrochloride |
|
|
466 | Fenfluramine Tablets | 525 | Gauze, X-Ray-Detectable Absorbent Cotton and Viscose |
467 | Fenoprofen Calcium |
|
|
468 | Fenoprofen Calcium Tablets | 526 | Gauze, X-Ray-Detectable Absorbent Cotton and Viscose Ribbon |
469 | Fentanyl Citrate |
|
|
470 | Feprazone | 527 | Gauze, X-Ray-Detectable Absorbent Cotton Ribbon |
471 | Feprazone Capsules |
|
|
472 | Ferric Citrate (59Fe) Injection | 528 | Gelatin Sponge, Absorbable |
473 | Ferrous Fumarate | 529 | Gentamicin Cream |
474 | Ferrous Fumarate Tablets | 530 | Gentamicin Eye Drops |
475 | Ferrous Succinate | 531 | Gentamicin Ointment |
476 | Ferrous Succinate Capsules | 532 | Gentamicin Sulphate |
477 | Ferrous Succinate Tablets | 533 | Gentian |
478 | Ferrous Sulphate Mixture, Paediatric | 534 | Ginger |
479 | Ferrous Sulphate Tablets | 535 | Ginger Tincture, Strong |
480 | Fibrinogen, Dried | 536 | Ginger Tincture, Weak |
481 | Fibrinogen for Isotopic Labelling, Dried | 537 | Glibenclamide |
|
| 538 | Globin Zinc Insulin Injection |
482 | Fig | 539 | Glucagon |
483 | Fig Elixir, Compound | 540 | Glutethimide |
484 | Film, Semipermeable Adhesive | 541 | Glutethimide Tablets |
485 | Flucytosine | 542 | Glycerol (85 per cent) |
486 | Fludrocortisone Acetate | 543 | Glycerol Suppositories |
487 | Flufenamic Acid | 544 | Glyceryl Monostearate |
488 | Flufenamic Acid Capsules | 545 | Glyceryl Monostearate Self-Emulsifying |
489 | Fluocinolone Acetonide |
|
|
490 | Fluocinolone Acetonide Cream | 546 | Glyceryl Trinitrate Solution, Concentrated |
491 | Fluocinolone Acetonide Ointment |
|
|
492 | Fluocortolone Hexanoate | 547 | Glycine |
493 | Fluocortolone Pivalate | 548 | Glycine Irrigation Solution |
494 | Fluorescein Sodium | 549 | Gold (198Au) Injection, Colloidal |
495 | Fluorescein Sodium Eye Drops | 550 | Gonadorelin |
496 | Fluorescein Sodium Injection | 551 | Gonadorelin Injection |
497 | Fluorouracil | 552 | Green S and Tartrazine Solution |
498 | Fluorouracil Cream | 553 | Griseofulvin |
499 | Fluoxymesterone | 554 | Guaiphenesin |
500 | Fluphenazine Decanoate | 555 | Guanethidine Monosulphate |
501 | Fluphenazine Enanthate | 556 | Halibut-liver Oil |
502 | Fluphenazine Enanthate Injection | 557 | Halibut-liver Oil Capsules |
503 | Flurazepam Monohydrochloride | 558 | Haloperidol Solution |
504 | Flurazepam Monohydrochloride Capsules | 559 | Halothane |
|
| 560 | Halquinol |
505 | Fractionated Coconut Oil | 561 | Helium |
506 | Fractionated Palm Kernel Oil | 562 | Heparin Calcium |
507 | Fructose | 563 | Heparin Sodium |
508 | Fructose Intravenous Infusion | 564 | Hexachlorophane |
509 | Furazolidone | 565 | Hexachlorophane Dusting Powder |
510 | Gallamine Injection | 566 | Hexylresorcinol |
511 | Gallamine Triethiodide | 567 | Homatropine Eye Drops |
512 | Gas Gangrene Antitoxin (Novyi) | 568 | Honey, Purified |
513 | Gas Gangrene Antitoxin (Perfringens) | 569 | Hyaluronidase Injection |
SCHEDULE 1—continued
570 | Hydralazine Hydrochloride | 624 | Iothalamic Acid |
571 | Hydralazine Hydrochloride Injection | 625 | Ipecacuanha |
572 | Hydrocortisone Acetate and Clioquinol Cream | 626 | Ipecacuanha and Morphine Mixture |
|
| 627 | Ipecacuanha Emetic Mixture, Paediatric |
573 | Hydrocortisone and Clioquinol Ointment |
|
|
|
| 628 | Ipecacuanha Liquid Extract |
574 | Hydrocortisone Hydrogen Succinate | 629 | Ipecacuanha, Prepared |
575 | Hydrocortisone Ointment | 630 | Isoniazid |
576 | Hydrocortisone Sodium Phosphate | 631 | Isoniazid Injection |
577 | Hydrocortisone Sodium Phosphate Injection | 632 | Isoprenaline Hydrochloride Injection |
|
| 633 | Isoprenaline Sulphate |
578 | Hydroflumethiazide | 634 | Isopropyl Myristate |
579 | Hydroflumethiazide Tablets | 635 | Isosorbide Dinitrate, Diluted |
580 | Hydrogen Peroxide Ear Drops | 636 | Isoxsuprine Hydrochloride |
581 | Hydrogen Peroxide Solution (30 per cent) | 637 | Isoxsuprine Hydrochloride Injection |
|
| 638 | Isoxsuprine Hydrochloride Tablets |
582 | Hydrogen Peroxide Solution (27 per cent) | 639 | Ispaghula Husk |
|
| 640 | Kanamycin Acid Sulphate |
583 | Hydrogen Peroxide Solution (6 per cent) | 641 | Kanamycin Sulphate |
|
| 642 | Kaolin and Morphine Mixture |
584 | Hydroxocobalamin | 643 | Kaolin, Heavy |
585 | Hydroxocobalamin Injection | 644 | Kaolin Mixture |
586 | Hydroxychloroquine Sulphate | 645 | Kaolin Mixture, Paediatric |
587 | Hydroxyprogesterone Hexanoate | 646 | Kaolin Poultice |
588 | Hydroxyprogesterone Injection | 647 | Ketoprofen |
589 | Hydroxyurea | 648 | Ketoprofen Capsules |
590 | Hyoscine Butylbromide | 649 | Lactic Acid Pessaries |
591 | Hyoscine Butylbromide Tablets | 650 | Lanatoside C |
592 | Hyoscine Eye Drops | 651 | Lavender Oil |
593 | Hyoscine Eye Ointment | 652 | Lemon Oil |
594 | Hyoscine Injection | 653 | Lemon Oil, Terpeneless |
595 | Hyoscine Methobromide | 654 | Lemon Peel, Dried |
596 | Hyoscine Methobromide Tablets | 655 | Lemon Syrup |
597 | Hyoscine Methonitrate | 656 | Levallorphan Injection |
598 | Hyoscine Tablets | 657 | Levallorphan Tartrate |
599 | Hyoscyamus Dry Extract | 658 | Levamisole Hydrochloride |
600 | Hyoscyamus Leaf | 659 | Levodopa Capsules |
601 | Hyoscyamus Prepared | 660 | Levorphanol Injection |
602 | Hyoscyamus Tincture | 661 | Levorphanol Tablets |
603 | Ibuprofen | 662 | Levorphanol Tartrate |
604 | Indomethacin | 663 | Lignocaine and Adrenaline Injection |
605 | Influenza Vaccine Adsorbed, Inactivated | 664 | Lignocaine Hydrochloride and Chlorhexidine Gluconate Gel |
|
|
|
|
606 | Influenza Vaccine, Inactivated | 665 | Lignocaine Hydrochloride Gel |
607 | Influenza Vaccine Live (Intranasal) | 666 | Lincomycin Capsules |
608 | Influenza Vaccine (Surface Antigen), Inactivated | 667 | Lincomycin Hydrochloride |
|
| 668 | Lindane Application |
609 | Industrial Methylated Spirit | 669 | Linseed |
610 | Industrial Methylated Spirit (Ketone-free) | 670 | Liothyronine Sodium |
|
| 671 | Liquorice |
611 | Inositol Nicotinate | 672 | Lithium Carbonate Tablets, Slow |
612 | Inositol Nicotinate Tablets | 673 | Lobelia |
613 | Insulin | 674 | Lomustine |
614 | Inulin | 675 | Lomustine Capsules |
615 | Inulin Injection | 676 | Lorazepam |
616 | Invert Syrup | 677 | Lymecycline |
617 | Iodinated (125I) Albumin Injection | 678 | Lymecycline and Procaine Injection |
618 | Iodinated (131I) Albumin Injection | 679 | Lymecycline Capsules |
619 | Iodipamide Meglumine Injection | 680 | Lynoestrenol |
620 | Iodised Oil Fluid Injection | 681 | Lypressin Injection |
621 | Iopanoic Acid | 682 | Macrogol 300 |
622 | Iopanoic Acid Tablets | 683 | Macrogol 1540 |
623 | Iophendylate Injection | 684 | Macrogol 4000 |
SCHEDULE 1—continued
685 | Macrogol Ointment | 745 Methyldopate Hydrochloride |
686 | Magnesium Acetate | 746 Methyldopate Injection |
687 | Magnesium Carbonate, Heavy | 747 Methyl Hydroxybenzoate |
688 | Magnesium Carbonate Mixture, Aromatic | 748 Methyl Nicotinate |
|
| 749 Methylprednisolone Acetate |
689 | Magnesium Hydroxide Mixture | 750 Methylprednisolone Tablets |
690 | Magnesium Oxide, Heavy | 751 Methyltestosterone |
691 | Magnesium Oxide, Light | 752 Methylprylone |
692 | Magnesium Stearate | 753 Methylprylone Tablets |
693 | Magnesium Sulphate Mixture | 754 Methysergide Maleate |
694 | Magnesium Trisilicate Mixture | 755 Metyrapone |
695 | Magnesium Trisilicate Oral Powder, Compound | 756 Metyrapone Capsules |
|
| 757 Mexenone |
696 | Magnesium Trisilicate Tablets, Compound | 758 Mexenone Cream |
|
| 759 Mexiletine Hydrochloride |
697 | Maize Oil | 760 Mianserin Hydrochloride |
698 | Maleic Acid | 761 Mint Oil, Dementholised |
699 | Manganese Sulphate | 762 Mitobronitol |
700 | Mannitol | 763 Mitobronitol Tablets |
701 | Mannitol Intravenous Infusion | 764 Monosulfiram |
702 | Mastic | 765 Monosulfiram Solution |
703 | Mastic Paint, Compound | 766 Morphine and Atropine Injection |
704 | Matricaria Flowers | 767 Morphine Sulphate Tablets |
705 | Measles Vaccine, Live | 768 Mouthwash Solution-Tablets |
706 | Meclozine Hydrochloride | 769 Muslin, Absorbent |
707 | Mefenamic Acid | 770 Nalidixic Acid |
708 | Megestrol Acetate | 771 Nalorphine Hydrobromide |
709 | Meglumine | 772 Nalorphine Injection |
710 | Meglumine Diatrizoate Injection | 773 Nandrolone Decanoate |
711 | Meglumine Iothalamate Injection | 774 Nandrolone Phenylpropionate |
712 | Melarsoprol Injection | 775 Neomycin Sulphate Elixir |
713 | Melphalan | 776 Neomycin Sulphate Eye Drops |
714 | Melphalan Injection | 777 Neomycin Sulphate Eye Ointment |
715 | Menthol and Benzoin Inhalation | 778 Neostigmine Bromide |
716 | Mepacrine Hydrochloride | 779 Neostigmine Methylsulphate |
717 | Mepacrine Tablets | 780 Niclosamide |
718 | Meprobamate | 781 Nicotinamide |
719 | Meprobamate Tablets | 782 Nicotinamide Tablets |
720 | Mepyramine Elixir | 783 Nicotinic Acid |
721 | Mepyramine Injection | 784 Nicoumalone |
722 | Mepyramine Maleate | 785 Nicoumalone Tablets |
723 | Mepyramine Tablets | 786 Nikethamide |
724 | Mercaptopurine | 787 Nikethamide Injection |
725 | Metaraminol Tartrate | 788 Nitrazepam |
726 | Metaraminol Tartrate Injection | 789 Nitrazepam Capsules |
727 | Metformin Hydrochloride | 790 Nitric Acid |
728 | Methadone Linctus | 791 Nitrofurazone |
729 | Methallenoestril | 792 Nitrous Oxide |
730 | Methallenoestril Tablets | 793 Noradrenaline Acid Tartrate |
731 | Methandienone | 794 Noradrenaline Injection |
732 | Methandienone Tablets | 795 Norethandrolone |
733 | Methaqualone | 796 Norethandrolone Tablets |
734 | Methisazone | 797 Norethynodrel |
735 | Methisazone Mixture | 798 Normal Immunoglobulin Injection |
736 | Methohexitone Injection | 799 Nortriptyline Capsules |
737 | Methoserpidine | 800 Noscapine |
738 | Methoserpidine Tablets | 801 Noscapine Hydrochloride |
739 | Methoxamine Hydrochloride | 802 Noscapine Linctus |
740 | Methoxamine Injection | 803 Nutmeg Oil |
741 | Methoxyflurane | 804 Nux Vomica |
742 | Methylcellulose | 805 Nux Vomica Liquid Extract |
743 | Methylcellulose Granules | 806 Nux Vomica Tincture |
744 | Methyldopa | 807 Nystatin (Dermatological) |
SCHEDULE 1—continued
808 | Octaphonium Chloride | 869 | Pentobarbitone Tablets |
809 | Octyl Gallate | 870 | Pentolinium Injection |
810 | Oestradiol Benzoate | 871 | Pentolinium Tartrate |
811 | Oestradiol Benzoate Injection | 872 | Peppermint Emulsion, Concentrated |
812 | Opiate Squill Pastilles | 873 | Peppermint Leaf |
813 | Opium | 874 | Peppermint Oil |
814 | Opium, Powdered | 875 | Perphenazine |
815 | Orange Oil | 876 | Perphenazine Injection |
816 | Orange Oil, Terpeneless | 877 | Perphenazine Tablets |
817 | Orange Peel, Dried Bitter- | 878 | Pertussis Vaccine |
818 | Orange Peel Infusion | 879 | Pertussis Vaccine, Adsorbed |
819 | Orange Peel Infusion, Concentrated | 880 | Pethidine Hydrochloride |
820 | Orange Spirit, Compound | 881 | Phenazone |
821 | Orciprenaline Injection | 882 | Phenelzine Sulphate |
822 | Orciprenaline Sulphate | 883 | Phenformin Hydrochloride |
823 | Orciprenaline Tablets | 884 | Phenformin Tablets |
824 | Orphenadrine Citrate | 885 | Phenindamine Tablets |
825 | Orphenadrine Citrate Tablets, Slow | 886 | Phenindamine Tartrate |
826 | Orphenadrine Hydrochloride | 887 | Phenindione |
827 | Oubain | 888 | Phenobarbitone Elixir |
828 | Oxazepam | 889 | Phenobarbitone Sodium Tablets |
829 | Oxazepam Capsules | 890 | Phenol and Glycerol Injection |
830 | Oxedrine Tartrate | 891 | Phenol Injection Oily |
831 | Oxygen | 892 | Phenolphthalein |
832 | Oxymetholone | 893 | Phenolphthalein Tablets |
833 | Oxyphenbutazone | 894 | Phenoxybenzamine Hydrochloride |
834 | Oxyphenbutazone Eye Ointment | 895 | Phenoxymethylpenicillin |
835 | Oxyphenbutazone Tablets | 896 | Phenoxymethylpenicillin Calcium |
836 | Oxytetracycline Calcium | 897 | Phenoxymethylpenicillin Mixture |
837 | Oxytetracycline Dihydrate | 898 | Phenoxymethylpenicillin Potassium |
838 | Oxytetracycline Injection | 899 | Phenoxymethylpenicillin Potassium Elixir |
839 | Oxytetracycline Tablets |
|
|
840 | Oxytocin Tablets | 900 | Phentolamine Injection |
841 | Pad, X-Ray-Detectable Abdominal | 901 | Phentolamine Mesylate |
842 | Pancreatic Extract | 902 | Phenylbutazone |
843 | Pancreatin Granules | 903 | Phenylbutazone Suppositories |
844 | Pancreatin Tablets | 904 | Phenylbutazone Tablets. |
845 | Pancuronium Bromide | 905 | Phenylephrine Hydrochloride Injection |
846 | Pancuronium Injection | 906 | Phenylmercuric Borate |
847 | Papaverine Hydrochloride | 907 | Phenylmercuric Nitrate |
848 | Paracetamol Elixir, Paediatric | 908 | Phenylpropanolamine Hydrochloride |
849 | Paraffin Emulsion, Liquid | 909 | Phenytoin Sodium |
850 | Paraffin and Magnesium Hydroxide Emulsion, Liquid | 910 | Phenytoin Tablets |
|
| 911 | Pholcodine Linctus |
851 | Paraffin and Phenolphthalein Emulsion, Liquid | 912 | Pholcodine Linctus, Strong |
|
| 913 | Phosphates Enema |
852 | Paraldehyde | 914 | Phosphoric Acid |
853 | Paraldehyde Injection | 915 | Phosphoric Acid, Dilute |
854 | Pastille Basis | 916 | Phthalylsulphathiazole |
855 | Penicillamine Capsules | 917 | Physostigmine Eye Drops |
856 | Pentaerythritol Tablets | 918 | Physostigmine Salicylate |
857 | Pentagastrin | 919 | Physostigmine Sulphate |
858 | Pentagastrin Injection | 920 | Phytomenadione |
859 | Pentamidine Injection | 921 | Phytomenadione Tablets |
860 | Pentamidine Isethionate | 922 | Pilocarpine Eye Drops |
861 | Pentazocine | 923 | Piperazine Adipate |
862 | Pentazocine Hydrochloride | 924 | Piperazine Citrate |
863 | Pentazocine Lactate Injection | 925 | Piperazine Citrate Elixir |
864 | Pentazocine Tablets | 926 | Piperazine Hydrate |
865 | Pentetrazol | 927 | Piperazine Phosphate |
866 | Pentobarbitone | 928 | Piperazine Phosphate Tablets |
867 | Pentobarbitone Capsules | 929 | Plasma, Dried |
868 | Pentobarbitone Sodium | 930 | Plasma, Fresh Frozen |
SCHEDULE 1—continued
931 | Plasma Protein Fraction | 988 | Propantheline Bromide |
932 | Plasma Protein Fraction, Dried | 989 | Propranolol Hydrochloride |
933 | Plaster, Belladonna Adhesive | 990 | Propyl Gallate |
934 | Plaster, Extension | 991 | Propyl Hydroxybenzoate |
935 | Plaster, Salicylic Acid Adhesive | 992 | Propyliodone |
936 | Poldine Methylsulphate | 993 | Propyliodone Oily Suspension |
937 | Poldine Tablets | 994 | Propyliodone Suspension |
938 | Poliomyelitis Vaccine (Inactivated) | 995 | Propylthiouracil |
939 | Poliomyelitis Vaccine, Live (Oral) | 996 | Prothionamide |
940 | Polymyxin B Sulphate and Bacitracin Zinc Eye Ointment | 997 | Prothionamide Tablets |
|
| 998 | Protriptyline Hydrochloride |
941 | Polysorbate 20 | 999 | Protriptyline Tablets |
942 | Polysorbate 60 | 1000 | Proxymetacaine Hydrochloride |
943 | Polysorbate 80 | 1001 | Proxymetacaine Hydrochloride Eye Drops |
944 | Polythiazide |
|
|
945 | Polythiazide Tablets | 1002 | Proxyphylline |
946 | Potassium Acetate | 1003 | Pseudoephedrine Hydrochloride |
947 | Potassium Bromide | 1004 | Pyrazinamide |
948 | Potassium Chloride and Glucose Intravenous Infusion | 1005 | Pyrazinamide Tablets |
|
| 1006 | Pyridostigmine Bromide |
949 | Potassium Chloride and Sodium Chloride Intravenous Infusion | 1007 | Pyroxylin |
|
| 1008 | Quillaia |
950 | Potassium Chloride, Sodium Chloride and Glucose Intravenous Infusion | 1009 | Quillaia Liquid Extract |
|
| 1010 | Quillaia Tincture |
951 | Potassium Chloride Tablets, Effervescent | 1011 | Quinalbarbitone Capsules |
|
| 1012 | Quinalbarbitone Sodium |
952 | Potassium Citrate Mixture | 1013 | Quinalbarbitone Tablets |
953 | Potassium Hydroxide | 1014 | Quinine Bisulphate |
954 | Potassium Hydroxide Solution | 1015 | Quinine Dihydrochloride |
955 | Potassium Nitrate | 1016 | Quinine Dihydrochloride Injection |
956 | Potassium Sorbate | 1017 | Quinine Hydrochloride |
957 | Povidone | 1018 | Quinine Sulphate |
958 | Povidone-Iodine Solution | 1019 | Rabies Antiserum |
959 | Practolol | 1020 | Raspberry Juice, Concentrated |
960 | Practolol Injection | 1021 | Reserpine |
961 | Prednisolone Pivalate | 1022 | Reserpine Tablets |
962 | Prednisolone Pivalate Injection | 1023 | Rhatany Root |
963 | Prednisolone Sodium Phosphate Injection | 1024 | Rhubarb |
|
| 1025 | Rhubarb and Soda Mixture, Ammoniated |
964 | Prednisone |
|
|
965 | Pregelatinised Maize Starch | 1026 | Rhubarb Mixture, Compound |
966 | Prenylamine Lactate | 1027 | Rhubarb Oral Powder, Compound |
967 | Prenylamine Lactate Tablets | 1028 | Rhubarb Tincture, Compound |
968 | Prilocaine Hydrochloride | 1029 | Riboflavine Sodium Phosphate |
969 | Primaquine Phosphate | 1030 | Rifamycin Sodium |
970 | Primidone | 1031 | Rubella Vaccine, Live |
971 | Primidone Mixture | 1032 | Saccharin |
972 | Probenecid | 1033 | Saccharin Sodium |
973 | Procainamide Tablets | 1034 | Salbutamol Sulphate Injection |
974 | Procaine and Adrenaline Injection | 1035 | Salsalate |
975 | Procaine Hydrochloride | 1036 | Salsalate Capsules |
976 | Prochlorperazine Maleate | 1037 | Schick Test Toxin |
977 | Prochlorperazine Mesylate | 1038 | Schick Control |
978 | Procyclidine Hydrochloride | 1039 | Scorpion Venom Antiserum |
979 | Progesterone | 1040 | Secbutobarbitone |
980 | Progesterone Injection | 1041 | Selenium Sulphide |
981 | Proguanil Hydrochloride | 1042 | Selenium Sulphide Scalp Application |
982 | Promazine Hydrochloride | 1043 | Senega Infusion, Concentrated |
983 | Promazine Injection | 1044 | Senega Liquid Extract |
984 | Promazine Tablets | 1045 | Senega Root |
985 | Promethazine Hydrochloride | 1046 | L-Selenomethionine (75Se) Injection |
986 | Promethazine Theoclate | 1047 | Senna Fruit, Alexandrian |
987 | Propanidid | 1048 | Senna Fruit, Tinnevelly |
SCHEDULE 1—continued
1049 | Senna Leaf | 1105 | Sorbitan Monolaurate |
1050 | Senna Liquid Extract | 1106 | Sorbitan Mono-oleate |
1051 | Senna Tablets | 1107 | Sorbitan Monostearate |
1052 | Serum Gonadotropin | 1108 | Sorbitol |
1053 | Serum Gonadotrophin Injection | 1109 | Sorbitol Intravenous Infusion |
1054 | Sesame Oil | 1110 | Sorbitol for Parenteral Use |
1055 | Silver Nitrate, Toughened | 1111 | Sorbitol Solution (70 per cent) |
1056 | Simple Linctus | 1112 | Soya Oil |
1057 | Smallpox Vaccine | 1113 | Spearmint Oil |
1058 | Smallpox Vaccine, Dried | 1114 | Spironolactone |
1059 | Soda Lime | 1115 | Squill |
1060 | Sodium Aminosalicylate | 1116 | Squill, Indian |
1061 | Sodium Aurothiomalate | 1117 | Squill Liquid Extract |
1062 | Sodium Benzoate | 1118 | Squill Opiate Linctus |
1063 | Sodium Bicarbonate Compound Tablets | 1119 | Squill Opiate Linctus, Paediatric |
|
| 1120 | Squill Tincture |
1064 | Sodium Butyl Hydroxybenzoate | 1121 | Squill Vinegar |
1065 | Sodium Calciumedetate Injection | 1122 | Stanolone |
1066 | Sodium Carbonate Decahydrate | 1123 | Stanozolol |
1067 | Sodium Carbonate Monohydrate | 1124 | Stanozolol Tablets |
1068 | Sodium Chloride and Glucose Oral Powder, Compound | 1125 | Sterilizable Maize Starch |
|
| 1126 | Stilboestrol |
1069 | Sodium Chloride Mouthwash, Compound | 1127 | Stilboestrol Pessaries |
|
| 1128 | Stockinette, Cotton and Viscose Surgical Tubular |
1070 | Sodium Chloride Tablets |
|
|
1071 | Sodium Chromate (51Cr) Sterile Solution | 1129 | Stockinette, Cotton Surgical Tubular |
|
| 1130 | Stockinette, Ribbed Cotton and Viscose Surgical Tubular |
1072 | Sodium Citrate Tablets |
|
|
1073 | Sodium Diatrizoate | 1131 | Stockinette, Ribbed Cotton Surgical Tubular |
1074 | Sodium Diatrizoate Injection |
|
|
1075 | Sodium Ethacrynate Injection | 1132 | Stockinette, Viscose Surgical Tubular |
1076 | Sodium Fluoride | 1133 | Storax, Prepared |
1077 | Sodium Fusidate Capsules | 1134 | Stramonium Leaf |
1078 | Sodium Hydroxide | 1135 | Stramonium, Prepared |
1079 | Sodium Hypochlorite Solution, Dilute | 1136 | Succinylsulphathiazole |
1080 | Sodium Iodide | 1137 | Sucrose |
1081 | Sodium Iodide (131I) Injection | 1138 | Sulindac |
1082 | Sodium Iodide (13II) Solution | 1139 | Sulphacetamide Sodium Eye Drops |
1083 | Sodium Iodohippurate (13II) Injection | 1140 | Sulphacetamide Sodium Eye Ointment |
1084 | Sodium Iothalamate Injection | 1141 | Sulphadiazine |
1085 | Sodium Lauryl Sulphate | 1142 | Sulphadiazine Injection |
1086 | Sodium Metabisulphite | 1143 | Sulphadiazine Tablets |
1087 | Sodium Methyl Hydroxybenzoate | 1144 | Sulphadimethoxine |
1088 | Sodium Perborate | 1145 | Sulphadimethoxine Tablets |
1089 | Sodium Pertechnetate (99mTc) Injection (Fission) | 1146 | Sulphadimidine |
|
| 1147 | Sulphadimidine Injection |
1090 | Sodium Pertechnetate (99mTc) Injection (Non-fission) | 1148 | Sulphadimidine Mixture, Paediatric |
|
| 1149 | Sulphadimidine Sodium |
1091 | Sodium Phosphate (32P) Injection | 1150 | Sulphamethoxazole |
1092 | Sodium Propyl Hydroxybenzoate | 1151 | Sulphamethoxydiazine |
1093 | Sodium Salicylate Mixture | 1152 | Sulphamethoxydiazine Tablets |
1094 | Sodium Salicylate Mixture, Strong | 1153 | Sulphamethoxypyridazine |
1095 | Sodium Starch Glycollate | 1154 | Sulphamethoxypyridazine Tablets |
1096 | Sodium Stibogluconate | 1155 | Sulphapyridine |
1097 | Sodium Stibogluconate Injection | 1156 | Sulphathiazole |
1098 | Sodium Sulphate | 1157 | Sulphathiazole Tablets |
1099 | Sodium Sulphate, Anhydrous | 1158 | Sulphinpyrazone |
1100 | Sodium Sulphite, Anhydrous | 1159 | Sulphobromophthalein Sodium |
1101 | Sodium Tetradecyl Sulphate Concentrate | 1160 | Sulphuric Acid |
|
| 1161 | Sulphuric Acid, Dilute |
1102 | Sodium Tetradecyl Sulphate Injection | 1162 | Sulthiame |
1103 | Sodium Thiosulphate | 1163 | Surgical Spirit |
1104 | Sorbic Acid | 1164 | Suture, Sterile Braided Silk |
SCHEDULE 1—continued
1165 | Suture, Sterile Linen | 1217 | Thrombin, Dried |
1166 | Suture, Sterile Monofilament Stainless Steel | 1218 | Thymol Glycerin, Compound |
|
| 1219 | Thymoxamine Hydrochloride |
1167 | Suture, Sterile Plaited Stainless Steel | 1220 | Thymoxamine Tablets |
1168 | Suture, Sterile Polyamide 6 | 1221 | Thyroxine Sodium |
1169 | Suture, Sterile Polyamide 6/6 | 1222 | Timolol Maleate |
1170 | Suture, Sterile Polyester | 1223 | Tissue, Gauze and Cellulose Wadding |
1171 | Suture, Sterile Reconstituted Collagen | 1224 | Tissue, Gauze and Cotton |
1172 | Suture, Sterile Twisted Stainless Steel | 1225 | Titanium Dioxide Paste |
1173 | Sutures, Sterile Non-Absorbable | 1226 | Tobramycin |
1174 | Suxamethonium Bromide | 1227 | Tolazamide |
1175 | Suxamethonium Bromide Injection | 1228 | Tolazoline Hydrochloride |
1176 | Suxamethonium Chloride | 1229 | Tolazoline Tablets |
1177 | Suxamethonium Chloride Injection | 1230 | Tolbutamide |
1178 | Tamoxifen Citrate | 1231 | Tolnaftate |
1179 | Tape, Elastic Surgical Adhesive | 1232 | Tolu Balsam |
1180 | Tape, Impermeable | 1233 | Tolu-flavour Solution |
1181 | Tape, Impermeable Plastic Surgical Synthetic Adhesive | 1234 | Tolu Paediatric Compound Linctus |
|
| 1235 | Tranexamic Acid |
1182 | Tape, Permeable Non-woven Surgical Synthetic Adhesive | 1236 | Tranexamic Acid Injection |
|
| 1237 | Tranylcypromine Sulphate |
1183 | Tape, Permeable Plastic Surgical Adhesive | 1238 | Triamcinolone |
|
| 1239 | Triamcinolone Acetonide Dental Paste |
1184 | Tape, Permeable Plastic Surgical Synthetic Adhesive | 1240 | Triamcinolone Tablets |
|
| 1241 | Triamterene Capsules |
1185 | Tape, Permeable Woven Surgical Synthetic Adhesive | 1242 | Trichloroethylene |
|
| 1243 | Trichlorofluoromethane |
1186 | Tape, Semipermeable Waterproof Plastic Surgical Adhesive | 1244 | Triclofos Elixir |
|
| 1245 | Triclofos Sodium |
1187 | Tape, Zinc Oxide Surgical Adhesive | 1246 | Triclofos Tablets |
1188 | Tar | 1247 | Trimeprazine Tartrate |
1189 | Tartaric Acid | 1248 | Trimeprazine Tartrate Elixir, Paediatric |
1190 | Tartrazine Solution, Compound |
|
|
1191 | Technetium (99mTc) Colloidal Antimony Sulphide Injection | 1249 | Trimeprazine Tartrate Elixir, Strong Paediatric |
1192 | Technetium (99mTc) Colloidal Sulphur Injection | 1250 | Trimethoprim |
|
| 1251 | Trimipramine Maleate |
1193 | Technetium (99mTc) Tin Pyrophosphate Injection | 1252 | Triprolidine Hydrochloride |
|
| 1253 | Triprolidine Tablets |
1194 | Terpineol | 1254 | Trisodium Edetate Injection |
1195 | Testosterone Implants | 1255 | Tropicamide |
1196 | Testosterone Phenylpropionate Injection | 1256 | Troxidone |
|
| 1257 | Troxidone Capsules |
1197 | Tetanus Antitoxin | 1258 | Tuberculin, Old |
1198 | Tetanus Vaccine | 1259 | Tubocurarine Chloride |
1199 | Tetrachloroethylene | 1260 | Tubocurarine Injection |
1200 | Tetracosactrin | 1261 | Turpentine Oil |
1201 | Tetracosactrin Injection | 1262 | Typhoid and Tetanus Vaccine |
1202 | Tetracycline Injection | 1263 | Undecenoic Acid |
1203 | Tetracycline Tablets | 1264 | Urea |
1204 | Theobroma Oil | 1265 | Valerian |
1205 | Theobromine | 1266 | Vanillin |
1206 | Theophylline Hydrate | 1267 | Vasopressin Injection |
1207 | Thiabendazole | 1268 | Vinyl Ether |
1208 | Thiambutosine | 1269 | Viprynium Embonate |
1209 | Thiambutosine Tablets | 1270 | Viprynium Mixture |
1210 | Thiamine Hydrochloride | 1271 | Viprynium Tablets |
1211 | Thiamphenicol | 1272 | Viscose |
1212 | Thioguanine | 1273 | Viscose, Matt |
1213 | Thiomersal | 1274 | Vitamin A Concentrate (Oily form), Synthetic |
1214 | Thiopentone Injection |
|
|
1215 | Thiopentone Sodium | 1275 | Vitamin A Ester Concentrate (Natural) |
1216 | Thiopropazate Hydrochloride |
|
|
SCHEDULE 1—continued
1276 | Wadding, Absorbent Cotton and Viscose | 1287 | Xenon (133Xe) Injection |
|
| 1288 | Xylometazoline Hydrochloride |
1277 | Wadding, Absorbent Viscose | 1289 | Xylometazoline Hydrochloride Nasal Drops |
1278 | Wadding, Cellulose |
|
|
1279 | Warfarin Sodium | 1290 | Xylose |
1280 | White Liniment | 1291 | Yellow Fever Vaccine, Live |
1281 | Wild Cherry Bark | 1292 | Zinc Chloride |
1282 | Wild Cherry Syrup | 1293 | Zinc Sulphate and Adrenaline Eye Drops |
1283 | Wool for Chiropody, Animal |
|
|
1284 | Wound Dressing, Impermeable Plastic | 1294 | Zinc Sulphate Eye Drops |
1285 | Wound Dressing, Permeable Plastic | 1295 | Zinc Sulphate Lotion |
1286 | Wound Dressing, Semipermeable Waterproof Plastic | 1296 | Zinc Undecenoate |
SCHEDULE 2 Sub-regulations 10 (3) and (4)
ALLOWABLE COMPOUNDS (IF ANY) OF CERTAIN DRUGS OR MEDICINAL PREPARATIONS
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
1 | Acetylcysteine, B.P............... | — |
2 | Acrylic Resin................... | — |
3 | Acyclovir..................... | — |
4 | Adrenaline Hydrochloride.......... | — |
5 | “ALBUMAID XP”............... | — |
6 | “ALFARE”.................... | — |
7 | Aluminium Hydroxide Mixture, B.P. | Light Kaolin, B.P., or Light Kaolin (Natural), B.P., with Aluminium Hydroxide Mixture, B.P. |
|
| Magnesium Hydroxide, B.P., with Aluminium Hydroxide Mixture, B.P. |
|
| Magnesium Hydroxide, B.P., with Oxethazaine and Aluminium Hydroxide Mixture, B.P. |
8 | Aluminium Hydroxide, Dried, B.P. | Magnesium Hydroxide, B.P., with Aluminium Hydroxide, Dried, B.P. |
|
| Magnesium Trisilicate, B.P., with Magnesium Hydroxide, B.P., and Aluminium Hydroxide, Dried, B.P. |
9 | Aluminium Sodium Silicate......... |
|
10 | Amiloride Hydrochloride, B.P........ | Hydrochlorothiazide, B.P., with Amiloride Hydrochloride, B.P. |
11 | Aminacrine Hydrochloride, B.P. 1968 | — |
12 | “AMINOGRAN FOOD SUPPLEMENT” | — |
13 | “AMINOGRAN MINERAL MIXTURE” | — |
14 | Amoxycillin Trihydrate, B.P......... | Potassium Clavulanate with Amoxycillin Trihydrate, B.P. |
|
| Purified Water, B.P., with Amoxycillin Trihydrate, B.P. |
|
| Purified Water, B.P., with Potassium Clavulanate and Amoxycillin Trihydrate, B.P. |
15 | Amphotericin, B.P................ | — |
16 | Ampicillin Trihydrate, B.P.......... | Purified Water, B.P., with Ampicillin Trihydrate, B.P. |
17 | Antazoline Phosphate............. | Naphazoline Hydrochloride with Antazoline Phosphate |
18 | Antazoline Sulphate.............. | Naphazoline Nitrate, B.P., with Antazoline Sulphate |
19 | Ascorbic Acid, B.P............... | Ferrous Sulphate Mixture and Ferrous Sulphate Mixture C.F. of the Australian Pharmaceutical Formulary and Handbook |
|
| Ferrous Sulphate Mixture Prescribers’ List |
|
| Ferrous Sulphate Mixture Prescribers’ List Children’s Section |
20 | Atropine Eye Ointment, B.P......... | — |
21 | Atropine Methonitrate, B.P.......... | — |
22 | Azatadine Maleate............... | — |
23 | Bacitracin..................... | Neomycin Sulphate, B.P., with Polymyxin B Sulphate, B.P., and Bacitracin |
24 | Bacitracin Zinc, B.P............... | Neomycin Undecenoate with Bacitracin Zinc, B.P. Polymyxin B Sulphate, B.P., with Neomycin Sulphate, B.P., and Bacitracin Zinc, B.P. |
25 | “BANISH”.................... | — |
26 | Bassorin...................... | Frangula Bark, B.P., with Bassorin |
SCHEDULE 2—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
27 | Beclomethasone Dipropionate, B.P..... | — |
28 | Benserazide.................... | Levodopa, B.P., with Benserazide |
29 | Benzalkonium Chloride............ | — |
30 | Benzathine Penicillin, B.P........... | Procaine Penicillin, B.P., with Benzylpenicillin Potassium, B.P., and Benzathine Penicillin, B.P., in Water for Injections |
31 | Benzyl Benzoate, B.P.............. | — |
32 | Benzyl Benzoate Application, B.P...... | — |
33 | Benzylpenicillin Potassium, B.P....... | Benzathine Penicillin, B.P., with Procaine Penicillin, B.P., and Benzylpenicillin Potassium. B.P., in Water for Injections |
34 | Betamethasone Acetate............ | Betamethasone Sodium Phosphate, B.P., with Betamethasone Acetate |
35 | Betamethasone Dipropionate........ | — |
36 | Betamethasone Sodium Phosphate, B.P. | Betamethasone Acetate with Betamethasone Sodium Phosphate, B.P. |
37 | Betamethasone Valerate, B.P......... | — |
38 | Betamethasone Valerate Cream, B.P.... | — |
39 | Betamethasone Valerate Ointment, B.P. | — |
40 | Bisacodyl, B.P.................. | Dioctyl Sodium Sulphosuccinate, B.P.C. 1973, with Bisacodyl, B.P. |
41 | Brompheniramine Maleate.......... | — |
42 | Butyl Monoester Polymer........... | Ethanol, B.P., with Butyl Monoester Polymer |
|
| Isopropyl Alcohol, B.P., with Butyl Monoester Polymer |
43 | Caffeine, B.P................... | Ergotamine Tartrate, B.P., with Cyclizine Hydrochloride, B.P., and Caffeine, B.P. |
|
| Ergotamine Tartrate, B.P., with Caffeine, B.P. |
44 | Caffeine Citrate, B.P.C. 1959........ | Ergotamine Tartrate, B.P., with Diphenhydramine Hydrochloride, B.P., and Caffeine Citrate, B.P.C. 1959 |
45 | Calcium Carbonate, B.P............ | Calcium Lactate-Gluconate with Calcium Carbonate, B.P. |
46 | Calcium Chloride, B.P............. | Sodium Chloride, B.P., with Potassium Chloride, B.P., and Calcium Chloride, B.P., in Water for Injections |
47 | Calcium Lactate-Gluconate......... | Calcium Carbonate, B.P., with Calcium Lactate-Gluconate |
48 | Camphor Compound Linctus........ | — |
49 | Carbachol, B.P. 1973.............. | — |
50 | Carbamazepine, B.P............... | — |
51 | Carmellose Sodium, B.P............ | Gelatin, B.P., and Pectin with Carmellose Sodium, B.P. |
52 | Cephalexin, B.P................. | Purified Water, B.P., with Cephalexin, B.P. |
53 | Chloral Hydrate, B.P.............. | — |
54 | Chloramphenicol, B.P.............. | Polymyxin B Sulphate, B.P., with Chloramphenicol, B.P. |
55 | Chloramphenicol Eye Drops, B.P...... | — |
56 | Chloramphenicol Eye Ointment, B.P.... | — |
57 | Chloramphenicol Palmitate Mixture, B.P. | — |
58 | Chlorhexidine Gluconate........... | — |
SCHEDULE 2—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
59 | Chlorpromazine Elixir, B.P.......... | — |
60 | Chlortetracycline................ | — |
61 | Chlortetracycline Hydrochloride, B.P... | — |
62 | Choline Theophyllinate, B.P......... | — |
63 | Citric Acid, B.P.................. | Glucose, Anhydrous, B.P., Sodium Chloride, B.P., Potassium Chloride, B.P., Sodium Citrate, B.P., and Citric Acid, B.P. |
64 | Clindamycin Palmitate Hydrochloride.. | Purified Water, B.P., with Clindamycin Palmitate Hydrochloride |
65 | Clotrimazole................... | — |
66 | Cloxacillin Sodium, B.P............ | Purified Water, B.P., with Cloxacillin Sodium, B.P. |
67 | Codeine Phosphate Linctus.......... | — |
68 | Colistin Sulphate, B.P.............. | Neomycin Sulphate, B.P., with Colistin Sulphate, B.P. |
69 | Co-trimoxazole Mixture, Paediatric.... | — |
70 | Cyclizine Hydrochloride, B.P......... | Ergotamine Tartrate, B.P., with Caffeine, B.P., and Cyclizine Hydrochloride, B.P. |
71 | Dapsone, B.P................... | Pyrimethamine, B.P., with Dapsone, B.P. |
72 | “DE-LACT INFANT”............. | — |
73 | Desmopressin.................. | — |
74 | Dexamethasone, B.P.............. | Framycetin Sulphate, B.P., with Gramicidin and Dexamethasone, B.P. |
75 | Dexamethasone Sodium Meta-sulphobenzoate | Framycetin Sulphate, B.P., with Gramicidin and Dexamethasone Sodium Metasulphobenzoate |
76 | Dextran 40 Intravenous Infusion, B.P... | Glucose, B.P., with Dextran 40 Intravenous Infusion, B.P. |
|
| Sodium Chloride, B.P., with Dextran 40 Intravenous Infusion, B.P. |
77 | Dextran 70.................... | Hypromellose 4500 with Dextran 70 |
78 | Dextran 70 Intravenous Infusion, B.P... | Glucose, B.P., with Dextran 70 Intravenous Infusion, B.P. |
|
| Sodium Chloride, B.P., with Dextran 70 Intravenous Infusion, B.P. |
79 | Diazepam, B.P.................. | — |
80 | Dienoestrol, B.P................. | — |
81 | Difenoxin Hydrochloride........... | Atropine Sulphate, B.P., with Difenoxin Hydrochloride |
82 | “DIGESTELACT”............... | — |
83 | Digoxin Elixir, Paediatric, B.P........ | — |
84 | Dihydrocodeine Tartrate, B.P......... | — |
85 | Dimethicones, B.P................ | — |
86 | Dioctyl Sodium Sulphosuccinate, B.P.C. 1973 | Bisacodyl, B.P., with Dioctyl Sodium Sulphosuccinate, B.P.C. 1973 |
87 | Diphenhydramine Elixir, B.P......... | — |
88 | Diphenhydramine Hydrochloride, B.P. | Ergotamine Tartrate, B.P., with Caffeine Citrate, B.P.C. 1959, and Diphenhydramine Hydrochloride, B.P. |
89 | Diphenoxylate Hydrochloride, B.P..... | Atropine Sulphate, B.P., with Diphenoxylate Hydrochloride, B.P. |
90 | Diphenylpyraline Hydrochloride, B.P... | — |
91 | Dipivefrine Hydrochloride.......... | — |
92 | Doxorubicin Hydrochloride......... | — |
93 | Econazole Nitrate, B.P............. | — |
94 | Econazole Nitrate Cream, B.P........ | — |
SCHEDULE 2—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
95 | Ecothiopate Iodide, B.P............ | — |
96 | Epicillin...................... | Purified Water, B.P., with Epicillin |
97 | Ergocalciferol, B.P................ | — |
98 | Ergotamine Tartrate, B.P............ | Caffeine Citrate, B.P.C. 1959, with Diphenhydramine Hydrochloride, B.P., and Ergotamine Tartrate, B.P. |
|
| Caffeine, B.P., with Cyclizine Hydrochloride, B.P., and Ergotamine Tartrate, B.P. |
|
| Caffeine, B.P., with Ergotamine Tartrate, B.P. |
99 | Erythromycin Estolate, B.P.......... | — |
100 | Erythromycin Ethylsuccinate........ | Erythromycin Ethylsuccinate with Purified Water, B.P. |
101 | Erythromycin Stearate, B.P.......... |
|
102 | Ethanol, B.P.................... | Butyl Monoester Polymer with Ethanol, B.P. |
103 | Ethinylestradiol, B.P.............. | Ethynodiol Diacetate, B.P., with Ethinyloestradiol, B.P. |
|
| Levonorgestrel, B.P., with Ethinyloestradiol, B.P. |
|
| Norethisterone, B.P., with Ethinyloestradiol, B.P. |
|
| Norethisterone Acetate, B.P., with Ethinyloestradiol, B.P. |
|
| Norgestrel with Ethinyloestradiol, B.P. |
104 | Ethosuximide Elixir, B.P............ | — |
105 | Ethynodiol Diacetate, B.P........... | Ethinyloestradiol, B.P., with Ethynodiol Diacetate, B.P. |
106 | Fenoterol Hydrobromide........... | — |
107 | Ferrous Aminoacetosulphate......... | — |
108 | Ferrous Gluconate, B.P............. | — |
109 | Fluclorolone Acetonide............ | — |
110 | Flucloxacillin Sodium, B.P.......... | Purified Water, B.P., with Flucloxacillin Sodium, B.P. |
111 | Flumethasone Pivalate............. | Clioquinol, B.P., with Flumethasone Pivalate |
112 | Fluocortolone Pivalate and Fluocortolone Hexanoate Cream, B.P. |
|
113 | Fluocortolone Pivalate and Fluocortolone Hexanoate Ointment, B.P. | — |
114 | Fluphenazine Hydrochloride, B.P. | — |
115 | Fluorometholone................ | — |
116 | Folic Acid, B.P.................. | Ferrous Sulphate Dried, B.P., with Folic Acid, B.P. |
117 | Framycetin Sulphate, B.P........... | Dexamethasone, B.P., with Gramicidin and Framycetin Sulphate, B.P. |
|
| Gramicidin with Dexamethasone Sodium Meta-sulphobenzoate and Framycetin Sulphate, B.P. |
118 | Frangula Bark, B.P................ | Bassorin with Frangula Bark, B.P. |
119 | Frusemide, B.P.................. | — |
120 | Fusidic Acid, B.P................. | — |
121 | “GALACTOMIN, FORMULA No. 17” | — |
122 | “GALACTOMIN, FORMULA No. 19” | — |
123 | Gelatin, B.P.................... | Carmellose Sodium, B.P., with Pectin and Gelatin, B.P. |
124 | Glucose and Ketone Indicator-Urine | — |
SCHEDULE 2—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
125 | Glucose, Anhydrous, B.P........... | Sodium Chloride, B.P., Potassium Chloride, B.P., Citric Acid, B.P., Sodium Citrate, B.P., and Anhydrous Glucose, B.P. |
|
| Sodium Lactate Compound Intravenous Infusion, B.P., with Anhydrous Glucose, B.P. |
126 | Glucose Indicator—Blood.......... | — |
127 | Glucose Indicator—Urine.......... | — |
128 | “GLUCOSE NUTRAMIGEN”....... | — |
129 | Glycerophosphate Syrup, Compound... | — |
130 | Glyceryl Trinitrate............... | — |
131 | Gramicidin.................... | Framycetin Sulphate, B.P., with Dexamethasone, B.P., and Gramicidin |
|
| Framycetin Sulphate, B.P., with Dexamethasone Sodium Metasulphobenzoate and Gramicidin |
|
| Neomycin Sulphate, B.P., with Nystatin, B.P., Triamcinolone Acetonide, B.P., and Gramicidin |
|
| Polymyxin B Sulphate, B.P., with Neomycin Sulphate, B.P., and Gramicidin |
132 | Hydrochlorothiazide, B.P........... | Amiloride Hydrochloride, B.P., with Hydrochlorothiazide, B.P. |
|
| Triamterene, B.P., with Hydrochlorothiazide, B.P. |
133 | Hydrocortisone, B.P............... | Polymyxin B Sulphate, B.P., with Neomycin Sulphate, B.P., and Hydrocortisone, B.P. |
134 | Hydrocortisone Acetate, B.P......... | Neomycin Sulphate, B.P., with Hydrocortisone Acetate, B.P. |
135 | Hydrocortisone Acetate Ointment, B.P. | — |
136 | Hydrogen Peroxide Solution (3 per cent), B.P. |
|
137 | Hyoscine Hydrobromide, B.P......... | Atropine Sulphate, B.P., with Hyoscyamine Hydrobromide and Hyoscine Hydrobromide, B.P. |
|
| Atropine Sulphate, B.P., with Hyoscyamine Sulphate, B.P., and Hyoscine Hydrobromide, B.P. |
|
| Papaveretum, B.P.C. 1973, with Hyoscine Hydrobromide, B.P. |
138 | Hyoscyamine Hydrobromide......... | Atropine Sulphate, B.P., with Hyoscine Hydrobromide, B.P., and Hyoscyamine Hydrobromide |
139 | Hyoscyamine Sulphate, B.P.......... | Atropine Sulphate, B.P., with Hyoscine Hydrobromide, B.P., and Hyoscyamine Sulphate, B.P. |
140 | Hypromellose 4500............... | Dextran 70 with Hypromellose 4500 |
141 | Idoxuridine, B.P................. | — |
142 | Idoxuridine Eye Drops, B.P.......... | — |
143 | “INFASOY”................... | — |
144 | Insulin Injection, Isophane, B.P....... | Insulin Injection, Neutral, B.P., and Insulin Injection, Isophane, B.P. |
145 | Insulin Injection, Neutral, B.P........ | Insulin Injection, Isophane, B.P., and Insulin Injection, Neutral, B.P. |
146 | Ipratropium Bromide.............. | — |
147 | Isoconazole Nitrate............... | — |
148 | “ISOMIL”..................... | — |
149 | Isopropyl Alcohol, B.P............. | Butyl Monoester Polymer with lsopropyl Alcohol, B.P. |
|
| Isopropyl Monoester Polymer with lsopropyl Alcohol, B.P. |
150 | Isopropyl Monoester Polymer........ | Isopropyl Alcohol, B.P., with lsopropyl Monoester Polymer |
151 | “KETOVITE” Liquid............. | — |
SCHEDULE 2—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
152 | Lactulose Solution, B.P............. | — |
153 | Lauryldimethylbenzyl Ammonium Chloride | “TERIC N8” with Lauryldimethylbenzyl Ammonium Chloride |
154 | Levodopa, B.P.................. | Benserazide with Levodopa, B.P. |
155 | Levonorgestrel, B.P............... | Ethinyloestradiol, B.P., with Levonorgestrel, B.P. |
156 | Lindane, B.P.................... | — |
157 | Lindane Cream, B.P............... | — |
158 | “LOCASOL”................... | — |
159 | “LOFENALAC”................ | — |
160 | Lypressin..................... | — |
161 | Magnesium Chloride, B.P........... | Sodium Chloride, B.P., with Sodium Acetate, B.P., Sodium Gluconate, Potassium Chloride, B.P., and Magnesium Chloride, B.P. |
162 | Magnesium Hydroxide, B.P.......... | Aluminium Hydroxide, Dried, B.P., with Magnesium Hydroxide, B.P. |
|
| Aluminium Hydroxide, Dried, B.P., with Magnesium Trisilicate, B.P., and Magnesium Hydroxide, B.P. |
|
| Aluminium Hydroxide Mixture, B.P., with Magnesium Hydroxide, B.P. |
|
| Aluminium Hydroxide Mixture, B.P., with Oxethazaine and Magnesium Hydroxide, B.P. |
163 | Maldison..................... | — |
164 | “MAXAMAID XP”.............. | — |
165 | Medrysone.................... | — |
166 | Mestranol, B.P.................. | Norethisterone, B.P., with Mestranol, B.P. |
167 | Methylprednisolone, B.P............ | — |
168 | Metoclopramide Hydrochloride, B.P.... | — |
169 | Metronidazole Benzoate........... | — |
170 | Miconazole.................... | — |
171 | Miconazole Nitrate, B.P............ | — |
172 | Miconazole Nitrate Cream, B.P....... | — |
173 | Morphine Sulphate, B.P............ | Tacrine Hydrochloride with Morphine Sulphate, B.P. |
174 | Nalidixic Acid Mixture, B.P......... | — |
175 | Naphazoline Hydrochloride......... | Antazoline Phosphate with Naphazoline Hydrochloride |
176 | Naphazoline Nitrate, B.P............ | Antazoline Sulphate with Naphazoline Nitrate, B.P. |
177 | Natamycin.................... | — |
178 | Neomycin Sulphate, B.P............ | Bacitracin with Polymyxin B Sulphate, B.P., and Neomycin Sulphate, B.P. |
|
| Colistin Sulphate, B.P., with Neomycin Sulphate, B.P. |
|
| Gramicidin with Nystatin, B.P., Triamcinolone Acetonide, B.P., and Neomycin Sulphate, B.P. |
|
| Hydrocortisone Acetate, B.P., with Neomycin Sulphate, B.P. |
|
| Polymyxin B Sulphate, B.P., with Bacitracin Zinc, B.P., and Neomycin Sulphate, B.P. |
|
| Polymyxin B Sulphate, B.P., with Gramicidin and Neomycin Sulphate, B.P. |
|
| Polymyxin B Sulphate, B.P., with Hydrocortisone, B.P., and Neomycin Sulphate, B.P. |
179 | Neomycin Undecenoate............ | Bacitracin Zinc, B.P., with Neomycin Undecenoate |
180 | Nitrofurantoin Mixture, B.P.......... | — |
SCHEDULE 2—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
181 | Norethisterone, B.P............... | Ethinyloestradiol, B.P., with Norethisterone, B.P. Mestranol, B.P., with Norethisterone, B.P. |
182 | Norethisterone Acetate, B.P.......... | Ethinyloestradiol, B.P., with Norethisterone Acetate, B.P. |
183 | Norgestrel..................... | Ethinyloestradiol, B.P., with Norgestrel |
184 | Nortriptyline Hydrocholoride, B.P..... | — |
185 | Nystatin, B.P................... | Gramicidin with Neomycin Sulphate, B.P., Triamcinolone Acetonide, B.P., and Nystatin, B.P. |
|
| Tetracycline, B.P.C. 1973, with a buffering agent and Nystatin, B.P. |
|
| Tetracycline Hydrochloride, B.P., with Nystatin, B.P. |
186 | Nystatin Mixture, B.P.............. | — |
187 | Nystatin Ointment, B.P............. | — |
188 | “ODORTROL”................. | — |
189 | Oxytetracycline Hydrochloride, B.P.... | — |
190 | Oxethazaine................... | Aluminium Hydroxide Mixture, B.P., with Magnesium Hydroxide, B.P., and Oxethazaine |
191 | Pancreatin, B.P.................. | — |
192 | Papaveretum, B.P.C. 1973.......... | Hyoscine Hydrobromide, B.P., with Papaveretum, B.P.C. 1973 |
193 | Paracetamol, B.P................. | Codeine Phosphate, B.P., with Paracetamol, B.P. |
194 | Pectin........................ | Gelatin, B.P., with Carmellose Sodium, B.P., and Pectin |
|
| Kaolin Light, B.P., or Light Kaolin (Natural), B.P., with Pectin |
195 | Pericyazine.................... | — |
196 | Phenethicillin Potassium, B.P......... | Purified Water, B.P., with Phenethicillin Potassium, B.P. |
197 | Pheniramine Maleate, B.P........... | — |
198 | Phenoxymethylpenicillin (Benzathine or Hydrabamine salt) | — |
199 | Phenylephrine Hydrochloride, B.P..... | Prednisolone Acetate with Phenylephrine Hydrochloride, B.P. |
|
| Zinc Sulphate, B.P., with Phenylephrine Hydrochloride, B.P. |
200 | Phenytoin, B.P.C. 1973............ | — |
201 | Pholcodine, B.P.................. | — |
202 | Pilocarpine.................... | — |
203 | “PK AID I”.................... | — |
204 | “PK AID II”................... | — |
205 | Polyisobutylene................. | — |
206 | Polymyxin B Sulphate, B.P.......... | Bacitracin with Neomycin Sulphate, B.P., and Polymyxin B Sulphate, B.P. |
|
| Bacitracin Zinc, B.P., with Neomycin Sulphate, B.P., and Polymyxin B Sulphate, B.P. |
|
| Chloramphenicol, B.P., with Polymyxin B Sulphate, B.P. |
|
| Neomycin Sulphate, B.P., with Gramicidin and Polymyxin B Sulphate, B.P. |
|
| Neomycin Sulphate, B.P., with Hydrocortisone, B.P., and Polymyxin B Sulphate, B.P. |
207 | Polyvinyl Alcohol................ | — |
208 | Polyvinylpyrrolidone and Vinyl Acetate Copolymer | — |
SCHEDULE 2—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical, benefit | Allowable compounds (if any) |
209 | “PORTAGEN”................. | — |
210 | Potassium Chloride, B.P............ | Anhydrous Glucose, B.P., with Sodium Chloride, B.P., Citric Acid, B.P., Sodium Citrate, B.P., and Potassium Chloride, B.P. |
|
| Sodium Chloride, B.P., with Sodium Acetate, B.P., Sodium Gluconate, Magnesium Chloride, B.P., and Potassium Chloride, B.P. |
|
| Sodium Chloride, B.P., with Calcium Chloride, B.P., and Potassium Chloride, B.P., in Water for Injections |
211 | Potassium Clavulanate............. | Amoxycillin Trihydrate, B.P., with Potassium Clavulanate |
|
| Purified Water, B.P., with Amoxycillin Trihydrate, B.P., and Potassium Clavulanate |
212 | Prednisolone, B.P................ | — |
213 | Prednisolone Acetate.............. | Phenylephrine Hydrochloride, B.P., with Prednisolone Acetate |
214 | Prednisolone Sodium Phosphate, B.P. | — |
215 | “PREGESTIMIL”............... | — |
216 | Procaine Penicillin, B.P............ | Benzathine Penicillin, B.P., with Benzylpenicillin Potassium, B.P., and Procaine Penicillin, B.P., in Water for Injections |
217 | Promethazine Hydrochloride Elixir, B.P.. | — |
218 | “PROSOBEE”.................. | — |
219 | Pyrimethamine, B.P............... | Dapsone, B.P., with Pyrimethamine, B.P. |
|
| Sulfadoxine, B.P., with Pyrimethamine, B.P. |
220 | Salbutamol, B.P................. | — |
221 | Salbutamol Sulphate, B.P........... | — |
222 | Senega and Ammonia Mixture....... | — |
223 | Silver Sulphadiazine with Chlorhexidine Gluconate Cream | — |
224 | Sodium Acetate, B.P.............. | Sodium Chloride, B.P., with Potassium Chloride, B.P., Magnesium Chloride, B.P., Sodium Gluconate and Sodium Acetate, B.P. |
225 | Sodium Acid Citrate, B.P........... | — |
226 | Sodium Cromoglycate, B.P.......... | — |
227 | Sodium Gluconate............... | Sodium Chloride, B.P., with Sodium Acetate, B.P., Potassium Chloride, B.P., Magnesium Chloride, B.P., and Sodium Gluconate |
228 | Sodium Lactate Compound Intravenous Infusion, B.P. | Anhydrous Glucose, B.P., with Sodium Lactate Compound Intravenous Infusion, B.P. |
229 | Sodium Valproate Elixir, B.P......... | — |
230 | Sterculia, B.P................... | — |
231 | Sulfadoxine, B.P................. | Pyrimethamine, B.P., with Sulfadoxine, B.P. |
232 | Sulphacetamide Sodium, B.P......... | — |
233 | Sulphafurazole, B.P............... | — |
234 | Sulphamethizole, B.P ............. | — |
235 | Surgical Cement................. | — |
236 | Surgical Cement Solvent........... | — |
237 | Tacrine Hydrochloride............. | Morphine Sulphate, B.P., with Tacrine Hydrochloride |
238 | Terbutaline Sulphate, B.P........... | — |
239 | “TERIC N8”................... | Lauryldimethylbenzyl Ammonium Chloride with “TERIC N8” |
SCHEDULE 2—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
240 | Testosterone Decanoate, B.P......... | Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate, B.P., and Testosterone Decanoate, B.P. |
241 | Testosterone Isocaproate, B.P......... | Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., and Testosterone Isocaproate, B.P. |
|
| Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Decanoate, B.P., and Testosterone Isocaproate, B.P. |
242 | Testosterone Phenylpropionate, B.P.... | Testosterone Propionate, B.P., with Testosterone Isocaproate, B.P., and Testosterone Phenylpropionate, B.P. |
|
| Testosterone Propionate, B.P., with Testosterone Decanoate, B.P., Testosterone Isocaproate, B.P., and Testosterone Phenylpropionate, B.P. |
243 | Testosterone Propionate, B.P......... | Testosterone Isocaproate, B.P., with Testosterone Phenylpropionate, B.P., and Testosterone Propionate, B.P. |
|
| Testosterone Decanoate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate, B.P., and Testosterone Propionate, B.P. |
244 | Tetracycline, B.P.C. 1973........... | Tetracycline, B.P.C. 1973, with a buffering agent |
|
| Tetracycline, B.P.C. 1973, with a buffering agent and Nystatin, B.P. |
245 | Tetracycline Hydrochloride, B.P....... | Tetracycline Hydrochloride, B.P., with Nystatin, B.P. |
246 | Thioridazine Hydrochloride, B.P...... | — |
247 | Thiotepa, B.P................... | — |
248 | Timolol Maleate Eye Drops, B.P...... | — |
249 | Triamcinolone Acetonide, B.P........ | Gramicidin with Neomycin Sulphate, B.P., Nystatin, B.P., and Triamcinolone Acetonide, B.P. |
250 | Triamcinolone Acetonide Cream, B.P. |
|
251 | Triamcinolone Acetonide Ointment, B.P. | — |
252 | Triamterene, B.P................. | Hydrochlorothiazide, B.P., with Triamterene, B.P. |
253 | Triglycerides Oil, Medium Chain...... | — |
254 | Urea Cream, B.P................. | — |
255 | Vidarabine.................... | — |
256 | “ZERODOR”.................. | — |
257 | “ZOFF”...................... | — |
SCHEDULE 3
Sub-regulation 10 (2)
regulation 11 and
sub-regulation 35 (1)
DRUGS AND MEDICINAL PREPARATIONS ADDITIONAL TO THE DRUGS AND MEDICINAL PREPARATIONS IN THE BRITISH PHARMACOPOEIA
1 | Acetazolamide Sodium | 53 | Camphor Compound Linctus |
2 | Acriflavine, B.P.C. 1963 | 54 | Camphor Spirit, Compound, A.P.F. |
3 | Acrylic Resin | 55 | Captopril |
4 | Acyclovir | 56 | Carbachol, B.P. 1973 |
5 | Adrenaline Hydrochloride | 57 | Carindacillin Sodium |
6 | “ALBUMAID XP” | 58 | Cefotaxime Sodium |
7 | “ALFARÉ” | 59 | Cephazolin Sodium |
8 | Aluminium Acetate Solution, B.P.C. 1973 | 60 | Chlorhexidine Gluconate |
|
| 61 | Chlortetracycline |
9 | Aluminium Hydroxide and Magnesium Carbonate Co-dried Gel | 62 | Cholestyramine |
|
| 63 | Cimetidine |
10 | Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex | 64 | Clindamycin Palmitate Hydrochloride |
|
| 65 | Clonazepam |
11 | Aluminium Sodium Silicate | 66 | Clopamide |
12 | Amantadine Hydrochloride | 67 | Clorexolone |
13 | Ambenonium Chloride | 68 | Clotrimazole |
14 | Aminacrine Hydrochloride, B.P. 1968 | 69 | Coal Tar, Prepared, B.P. 1973 |
15 | Aminoglutethimide | 70 | Codeine Phosphate Linctus |
16 | “AMINOGRAN FOOD SUPPLEMENT” | 71 | Colestipol Hydrochloride |
|
| 72 | Copper Sulphate, B.P.C. 1973 |
17 | “AMINOGRAN MINERAL MIXTURE” | 73 | Danazol |
|
| 74 | Dantrolene Sodium |
18 | Amiodarone Hydrochloride | 75 | Death Adder Antivenom |
19 | Ammoniated Mercury, B.P. 1973 | 76 | “DE-LACT INFANT” |
20 | Antazoline Phosphate | 77 | Desmopressin |
21 | Antazoline Sulphate | 78 | Dexamethasone Sodium Metasulphobenzoate |
22 | Anthrax Antiserum |
|
|
23 | Anthrax Vaccine | 79 | Dexchlorpheniramine Maleate |
24 | Anti-Haemophilic Factor of Animal Origin | 80 | Dextran 70 |
|
| 81 | Diclofenac Sodium |
25 | Atenolol | 82 | Difenoxin Hydrochloride |
26 | Auranofin | 83 | “DIGESTELACT” |
27 | Aurothioglucose | 84 | Diltiazem Hydrochloride |
28 | Azatadine Maleate | 85 | Dioctyl Sodium Sulphosuccinate, B.P.C. 1973 |
29 | Bacitracin, B.P. 1968 |
|
|
30 | Baclofen | 86 | Diphtheria and Tetanus Vaccine, Adsorbed, B.P., Diluted |
31 | “BANISH” |
|
|
32 | Bassorin | 87 | Diphtheria Vaccine, Adsorbed, B.P., Diluted |
33 | Benserazide |
|
|
34 | Benzalkonium Chloride | 88 | Dipivefrine Hydrochloride |
35 | Betamethasone Acetate | 89 | Domperidone |
36 | Betamethasone Dipropionate | 90 | Doxorubicin Hydrochloride |
37 | Bethanechol Chloride | 91 | Enalapril Maleate |
38 | Biperiden Hydrochloride | 92 | Epicillin |
39 | Black Snake Antivenom | 93 | Erythromycin Ethylsuccinate |
40 | Bleomycin Sulphate | 94 | Erythromycin Gluceptate |
41 | Bromocriptine Mesylate | 95 | Erythromycin Lactobionate |
42 | Brompheniramine Maleate | 96 | Ethylnoradrenaline Hydrochloride |
43 | Brown Snake Antivenom | 97 | Etretinate |
44 | Bumetanide | 98 | Fenoterol Hydrobromide |
45 | Butyl Monoester Polymer | 99 | Ferrous Aminoacetosulphate |
46 | Cade Oil, B.P.C. 1973 | 100 | Flecainide Acetate |
47 | Caffeine Citrate, B.P.C. 1959 | 101 | Fluclorolone Acetonide |
48 | Calcitonin, Synthetic Human | 102 | Flumethasone Pivalate |
49 | Calcitriol | 103 | Fluorometholone |
50 | Calcium Folinate | 104 | Funnel-Web Spider Antivenom |
51 | Calcium Glubionate | 105 | “GALACTOMIN, FORMULA No. 17” |
52 | Calcium Lactate-Gluconate |
|
|
SCHEDULE 3—continued
106 | “GALACTOMIN, FORMULA No. 19” | 158 | Methenolone Acetate |
|
| 159 | Methsuximide |
107 | Gliclazide | 160 | Methyclothiazide |
108 | Glucagon Hydrochloride | 161 | Methylprednisolone Sodium Succinate |
109 | Glucose and Ketone Indicator—Urine | 162 | Methyl Salicylate Ointment, Compound, A.P.F. 1934 |
110 | Glucose Indicator—Blood |
|
|
111 | Glucose Indicator—Urine | 163 | Metolazone |
112 | “GLUCOSE NUTRAMIGEN” | 164 | Metoprolol Tartrate |
113 | Glycerophosphate Syrup, Compound | 165 | Metronidazole Benzoate |
114 | Glyceryl Trinitrate | 166 | Miconazole |
115 | Gramicidin | 167 | Minocycline Hydrochloride |
116 | Haemodialysis Solutions, B.P.C. 1973 | 168 | Minoxidil |
117 | Hexamine Hippurate | 169 | Misoprostol |
118 | Hexamine Mandelate | 170 | Mithramycin |
119 | Human Menopausal Gonadotrophin | 171 | Naloxone Hydrochloride |
120 | Hyoscyamine Hydrobromide | 172 | Naphazoline Hydrochloride |
121 | Hyoscyamus Liquid Extract, B.P.C. 1973 | 173 | Natamycin |
|
| 174 | Neomycin Undecenoate |
122 | Hypromellose 4500, B.P.C. 1973 | 175 | Nifedipine |
123 | “INFASOY” | 176 | Norgestrel |
124 | Injection of Potassium Chloride, B.P., with Sodium Lactate and Anhydrous Glucose, B.P. | 177 | “ODORTROL” |
|
| 178 | Oestradiol Valerate |
|
| 179 | Oestrone, B.P.C. 1954 |
125 | Insect Allergen Extract—Bull Ant | 180 | Ornidazole |
126 | Insect Allergen Extract—Honey Bee Venom | 181 | Oxethazaine |
|
| 182 | Oxycodone Hydrochloride |
127 | Insect Allergen Extract—Jumper Ant | 183 | Oxycodone Pectinate |
128 | Insect Allergen Extract—Mosquito | 184 | Pancrelipase |
129 | Insect Allergen Extract—Paper Wasp Venom | 185 | Papaveretum, B.P.C. 1973 |
|
| 186 | Paraffin Liquid Light, B.P.C. 1963 |
130 | Insulin, Human (Synthetic) | 187 | Paraffin Ointment, Yellow, B.P. 1968 |
131 | Insulin Isophane, Human (Synthetic) | 188 | Pectin |
132 | Intraperitoneal Dialysis Solutions, B.P.C. 1973 | 189 | Perhexiline Maleate |
|
| 190 | Pericyazine |
133 | Intraperitoneal Dialysis Solutions, Concentrated | 191 | Pheniramine Aminosalicylate |
|
| 192 | Phenoxymethylpenicillin, Benzathine |
134 | Ipratropium Bromide | 193 | Phenoxymethylpenicillin, Hydrabamine |
135 | Iron Polymaltose Complex |
|
|
136 | Isoconazole Nitrate | 194 | Phensuximide, B.P.C. 1973 |
137 | “ISOMIL” | 195 | Phenytoin, B.P.C. 1973 |
138 | Isopropyl Monoester Polymer | 196 | Pilocarpine |
139 | Isotretinoin | 197 | Pituitary Gonadotrophin, Human |
140 | “KETOVITE” Liquid | 198 | Pituitary Hormone, Growth, Human |
141 | “KETOVITE” Tablets | 199 | Pizotifen Malate |
142 | Labetalol Hydrochloride | 200 | “PK AID I” |
143 | Lauryldimethylbenzyl Ammonium Chloride | 201 | “PK AID II” |
|
| 202 | Plague Vaccine, B.P. 1973 |
144 | Lavender Oil, Spike, B.P.C. 1968 | 203 | Pneumococcal Vaccine, Polyvalent |
145 | Leuprorelin Acetate | 204 | Polyestradiol Phosphate |
146 | Lobelia Ethereal Tincture, B.P.C. 1973 | 205 | Polyisobutylene |
|
| 206 | Polyvinyl Alcohol |
147 | “LOCASOL” | 207 | Polyvinylpyrrolidone and Vinyl Acetate Copolymer |
148 | “LOFENALAC” |
|
|
149 | Loperamide Hydrochloride | 208 | “PORTAGEN” |
150 | Lypressin | 209 | Potassium Chloride, B.P., with Potassium Bicarbonate Effervescent Tablets |
151 | Magenta, B.P.C. 1973 |
|
|
152 | Maldison |
|
|
153 | “MAXAMAID XP” | 210 | Potassium Clavulanate |
154 | Medrysone | 211 | Pralidoxime Iodide |
155 | Mefruside | 212 | Prazosin Hydrochloride |
156 | Methacycline Hydrochloride, B.P. 1973 | 213 | Prednisolone Acetate |
|
| 214 | Prednisolone Stearoylglycolate |
157 | Methdilazine Hydrochloride | 215 | “PREGESTIMIL” |
SCHEDULE 3—continued
216 | Probucol | 241 | Surgical Cement |
217 | Procarbazine Hydrochloride | 242 | Surgical Cement Solvent |
218 | Prochlorperazine | 243 | Tacrine Hydrochloride |
219 | Prochlorperazine Edisylate | 244 | Taipan Antivenom |
220 | “PROSOBEE” | 245 | Temazepam |
221 | Pyrantel Embonate | 246 | “TER1C N8” |
222 | Quinethazone | 247 | Tetrabenazine |
223 | Ranitidine Hydrochloride | 248 | Tetracycline, B.P.C. 1973 |
224 | Red-Back Spider Antivenom | 249 | Thiethylperazine Malate |
225 | Red Syrup, A.P.F. | 250 | Thiethylperazine Maleate |
226 | Rolitetracycline | 251 | Thymol Mouth-Wash Compound, A.P.F. |
227 | Salicylamide |
|
|
228 | Sea Wasp Antivenom | 252 | Ticarcillin Sodium |
229 | Senega and Ammonia Mixture | 253 | Tiger Snake Antivenom |
230 | Siberian Fir Oil, B.P.C. 1949 | 254 | Tinidazole |
231 | Silver Sulphadiazine with Chlorhexidine Gluconate Cream | 255 | Triglycerides Oil, Medium Chain |
|
| 256 | Trimetaphan Camsylate, B.P. 1968 |
232 | Snake Bite Antivenom—Polyvalent | 257 | Trimipramine |
233 | Sodium Citro-Tartrate | 258 | Trioxysalen |
234 | Sodium Gluconate | 259 | Tri-potassium Di-citrato Bismuthate |
235 | Sodium Hypochlorite Solution 5.25% |
| Complex |
236 | Staphylococcus Toxoid, B.P. 1968 | 260 | Vasopressin Tannate |
237 | Stone Fish Antivenom | 261 | Vidarabine |
238 | Sucralfate | 262 | “ZERODOR” |
239 | Sulphasalazine | 263 | “ZOFF” |
240 | Sulphurated Potash, B.P.C. 1973 |
|
|
SCHEDULE 4 Regulation 12 and
sub-regulation 35 (1)
ADDITIVES
1 | Acetone, B.P. |
2 | Anise Water, Concentrated, B.P. |
3 | Arachis Oil, B.P. |
4 | Borax, B.P. |
5 | Boric Acid, B.P. |
6 | Castor Oil, B.P. |
7 | Chlorhexidine Acetate, B.P. |
8 | Chlorhexidine Gluconate Solution, B.P. |
9 | Chloroform, B.P. |
10 | Ethanol (96%), B.P. |
11 | Ethanols, Dilute, B.P. |
12 | Ether, Solvent, B.P. |
13 | Eucalyptus Oil, B.P. |
14 | Glucose, B.P. |
15 | Industrial Methylated Spirit, B.P. |
16 | Maize Oil, B.P. |
17 | Olive Oil, B.P. 1973 |
18 | Peppermint Water, Concentrated, A.P.F. |
19 | Peppermint Oil, B.P. |
20 | Pholcodine Citrate Syrup, B.P.C. 1959 |
21 | Sodium Thiosulphate, B.P. |
22 | Turpentine Oil, B.P. |
SCHEDULE 5 Sub-regulations 14 (1) and (2),
paragraphs 19 (1) (h) and 21 (1) (e)
and sub-regulation 22 (2)
PRESCRIBING OF PHARMACEUTICAL BENEFITS SUBJECT TO CONDITIONS AND RESTRICTIONS
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Classes of persons, diseases, &c., purposes and conditions specified in relation to the pharmaceutical benefit |
1 | Acetylcysteine, B.P............... | Bronchiectasis Cystic fibrosis (mucoviscidosis) |
2 | Acrylic Resin................... | Ileostomy or colostomy conditions |
3 | Acyclovir, Eye Ointment........... | Eye infections caused by herpes simplex virus where idoxuridine has proved ineffective |
4 | Acyclovir, Tablets............... | With the written authority of the Secretary— Suppression of genital herpes infection in immunocompromised patients |
5 | “ALBUMAID XP”............... | Phenylketonuria |
6 | “ALFARÉ”.................... | With the written authority of the Secretary— |
|
| Biliary atresia |
|
| Cystic fibrosis |
|
| Enterokinase deficiency |
|
| Intolerance to both milk protein and soya protein |
|
| Severe diarrhoea of greater than two weeks duration in infants under the age of 4 months |
7 | Amantadine Hydrochloride.......... | The treatment of Parkinson’s disease caused otherwise than by treatment with a drug |
8 | Aminoglutethimide............... | With the written authority of the Secretary— |
|
| Adrenal suppression in post-menopausal metastatic breast cancer in patients who have failed to respond adequately to primary endocrine manipulation |
|
| Cushing’s syndrome |
9 | (1) “AMINOGRAN FOOD SUPPLEMENT” | Phenylketonuria |
| (2) “AMINOGRAN MINERAL MIXTURE” |
|
10 | Amiodarone Hydrochloride......... | With the written authority of the Secretary — |
|
| For the continuing treatment of severe refractory cardiac arrhythmias where treatment with amiodarone hydrochloride was initiated in a hospital (in-patient or outpatient) |
|
| For the continuing treatment of a patient who has already received, for more than 6 months, therapy with amiodarone hydrochloride for severe refractory cardiac arrhythmias |
11 | Amoxycillin Trihydrate, B.P., Dispersible Tablets | Infection of the lower urinary tract |
12 | Amylobarbitone Sodium, B.P......... | Epilepsy |
13 | “BANISH”.................... | Ileostomy or colostomy conditions |
14 | Bassorin with Frangula Bark, B.P...... | Any disease or condition in a paraplegic or quadriplegic patient |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Classes of persons, diseases, &c., purposes and conditions specified in relation to the pharmaceutical benefit |
|
| For use by patients who are receiving long-term extensive nursing care in hospitals or nursing homes |
|
| For use by patients for whose care a Commonwealth Domiciliary Nursing Care Benefit is approved |
15 | Beclomethasone Dipropionate, B.P. | Chronic intractable asthma |
16 | Benzoin Compound Tincture, B.P., Aerosol Spray | Ileostomy or colostomy conditions |
17 | Betamethasone Acetate with Betamethasone Sodium Phosphate, B.P., Injection | Alopecia areata For local intra-articular or peri-articular infiltration |
|
| Granulomata, dermal |
|
| Keloid |
|
| Lichen planus hypertrophic |
|
| Lichen simplex chronicus |
|
| Lupus erythematosus, chronic discoid |
|
| Necrobiosis lipoidica |
|
| Uveitis |
18 | Bisacodyl, B.P.................. | Any disease or condition in a paraplegic or quadriplegic patient |
19 | (1) Bisacodyl Suppositories, B.P. | Any disease or condition in a paraplegic or quadriplegic patient |
| (2) Bisacodyl Tablets, B.P. |
|
|
| For use by patients who are receiving long-term extensive nursing care in hospitals or nursing homes |
|
| For use by patients for whose care a Commonwealth Domiciliary Nursing Care Benefit is approved |
20 | Bleomycin Sulphate.............. | Germ cell neoplasms |
|
| Lymphoma |
|
| Squamous cell carcinoma |
21 | (1) Bromocriptine Mesylate, Capsules, 5 mg (base) | With the written authority of the Secretary— |
| (2) Bromocriptine Mesylate, Capsules, 10 mg (base) | Acromegaly, prior to surgery or radiotherapy or where surgery or radiotherapy is inappropriate |
|
| Parkinson’s disease where treatment with levodopa is unsatisfactory |
|
| Pathological hyperprolactinaemia where appropriate surgery or radiotherapy are not indicated or have already been used with incomplete resolution |
22 | Bromocriptine Mesylate, Tablets, 2.5 mg (base) | Urgent suppression of physiological lactation |
|
| With the written authority of the Secretary— |
|
| Acromegaly, prior to surgery or radiotherapy or where surgery or radiotherapy is inappropriate |
|
| Parkinson’s disease where treatment with levodopa is unsatisfactory |
|
| Pathological hyperprolactinaemia where appropriate surgery or radiotherapy is not |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Classes of persons, diseases, &c., purposes and conditions specified in relation to the pharmaceutical benefit |
|
| indicated or has already been used with incomplete resolution |
23 | (1) Butyl Monoester Polymer with Ethanol, B.P. | Ileostomy or colostomy conditions |
| (2) Butyl Monoester Polymer with Isopropyl Alcohol, B.P. |
|
24 | Calciferol Tablets, High-Strength, B.P. | Hypocalcaemia |
|
| Hypoparathyroidism |
|
| Osteomalacia following gastrectomy, severe steatorrhoea or renal failure |
|
| Vitamin D-resistant rickets |
25 | Calcitriol..................... | With the written authority of the Secretary— |
|
| Hypocalcaemia due to renal disease |
|
| Hypoparathyroidism |
|
| Hypophosphataemic rickets |
|
| Vitamin D-resistant rickets |
26 | (1) Calcium Carbonate, B.P. | Hypocalcaemia |
| (2) Calcium Carbonate, B.P., with Calcium Lactate-Gluconate | Osteoporosis |
|
| Proven malabsorption |
27 | Calcium Folinate................ | Antidote to folic acid antagonists |
28 | Captopril..................... | Moderate or severe hypertension |
|
| For the continuing treatment of severe refractory cardiac failure where treatment with Captopril was initiated in a hospital (in-patient or outpatient) |
29 | Carbenicillin Sodium, B.P........... | Infections where positive bacteriological evidence confirms that carbenicillin is an appropriate therapeutic agent |
|
| Septicaemia, suspected or proven |
30 | Carindacillin Sodium.............. | With the written authority of the Secretary— |
|
| Urinary tract infections where positive bacteriological evidence confirms that carindacillin or carbenicillin is an appropriate therapeutic agent |
31 | (1) Carmellose Sodium, B.P. | Ileostomy or colostomy conditions |
| (2) Carmellose Sodium, B.P., with Pectin and Gelatin, B.P. |
|
32 | Cefotaxime Sodium.............. | Infections where positive bacteriological evidence confirms that cefotaxime sodium is an appropriate therapeutic agent |
|
| Septicaemia, suspected or proven |
33 | Cephazolin Sodium............... | Infections where positive bacteriological evidence confirms that cephazolin sodium is an appropriate therapeutic agent |
|
| Septicaemia, suspected or proven |
34 | Charcoal, Activated, B.P............ | Ileostomy or colostomy conditions |
35 | Chloramine, B.P................. | Ileostomy or colostomy conditions |
36 | (1) Chloramphenicol Capsules, B.P. | Bacterial meningitis |
|
| Intracranial bacterial infections |
| (2) Chloramphenicol Palmitate Mixture, B.P. | Intraocular infections |
|
| Rickettsioses |
| (3) Chloramphenicol Sodium Succinate, B.P. | Typhoid |
|
| Other serious infections where positive bacteriological evidence confirms that chloramphenicol is the only appropriate antibiotic |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Classes of persons, diseases, &c., purposes and conditions specified in relation to the pharmaceutical benefit |
37 | Chlormethiazole Capsules, B.P........ | With the written authority of the Secretary— |
|
| Short-term alcohol or drug withdrawal therapy in a hospital or approved centre |
|
| Status epilepticus |
38 | Chlormethiazole Edisylate, B.P....... | Short-term alcohol or drug withdrawal therapy in a hospital or approved centre |
|
| Status epilepticus |
39 | (1) Chlorpromazine Elixir, B.P. | Chorea |
| (2) Chlorpromazine Injection, B.P. | Hyperactive states of organic or toxic delirium |
|
| Major psychoses including— |
| (3) Chlorpromazine Suppositories, B.P. | Major organic pyschoses including arteriopathic dementia |
| (4) Chlorpromazine Tablets, B.P. | Manic depressive disorder—manic phase |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Severe conduct disorders in patients under the age of 16 years |
40 | Cholestyramine................. | Bile salt malabsorption associated with ileal resection or proven ileal disease |
|
| Hypercholesterolaemia |
|
| Pruritis associated with partial biliary obstruction not responding to other therapy |
|
| Severe diarrhoea associated with pelvic irradiation |
41 | Chorionic Gonadotrophin, B.P........ | For use with bromocriptine mesylate in infertility associated with hyperprolactinaemia |
42 | Cimetidine.................... | With the written authority of the Secretary— |
|
| Duodenal ulcer (including pyloric ulcer), confirmed by radiology, endoscopy or surgery |
|
| Gastric ulcer, confirmed by radiology, endoscopy or surgery |
|
| Severe ulcerating (erosive) oesophagitis, confirmed by endoscopy |
|
| Ulcerating (erosive) oesophagitis in scleroderma |
|
| Zoltinger-Ellison syndrome, proven by investigation |
43 | (1) Clindamycin Capsules, B.P. | Gram-positive coccal infections where the infection cannot be safely and effectively treated with penicillin or a derivative of penicillin |
| (2) Clindamycin Palmitate Hydrochloride |
|
44 | Clofibrate Capsules, B.P............ | With the written authority of the Secretary— |
|
| Hypertriglyceridaemia |
|
| Hypercholesterolaemia |
45 | Clomiphene Tablets, B.P............ | With the written authority of the Secretary— |
|
| Anovulatory infertility |
|
| Patients undergoing in-vitro fertilisation |
46 | Clomipramine Hydrochloride, B.P. | Cataplexy associated with narcolepsy |
|
| Obsessive compulsive disorders |
47 | (1) Cloxacillin Capsules, B.P. | Infections due to the presence of penicillin-resistant staphylococci |
| (2) Cloxacillin Sodium, B.P., with Purified Water, B.P. |
|
|
| Osteomyelitis |
48 | Colestipol Hydrochloride........... | Hypercholesterolaemia |
49 | Cyanocobalamin Injection, B.P....... | Pernicious anaemia and other proven Vitamin B12 deficiencies |
|
| Post-gastrectomy treatment |
|
| Sub-acute combined degeneration of the cord |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Classes of persons, diseases, &c., purposes and conditions specified in relation to the pharmaceutical benefit |
50 | Danazol...................... | With the written authority of the Secretary— |
|
| Endometriosis, proven by visual means Hereditary angio-oedema |
51 | Dantrolene Sodium............... | Treatment of chronic spasticity |
52 | “DE-LACT INFANT”............. | Acute gastro-enteritis complicated by lactose intolerance in infants under the age of 12 months |
|
| Proven lactose intolerance in infants under the age of 12 months |
53 | Demeclocycline Capsules, B.P........ | Syndrome of inappropriate antidiuretic hormone secretion, caused otherwise than by treatment with a drug |
54 | Deodorant Detergent Solution (Lauryldimethylbenzyl Ammonium Chloride and “TERIC N8”) | Any disease or condition in a paraplegic or quadriplegic patient |
|
| Ileostomy or colostomy conditions |
55 | Dexamethasone Sodium Phosphate, B.P., Injection equivalent of Dexamethasone Phosphate 120 mg in 5 mL | For use in a hospital |
56 | Dexamphetamine Tablets, B.P. | With the written authority of the Secretary— |
|
| For the treatment of a patient under the age of 21 years and who is hyperkinetic as a result of brain damage |
|
| Narcolepsy |
57 | (1) Dextromoramide Tablets, B.P. | Disabling pain associated with proven malignant neoplasia |
| (2) Dextromoramide Tartrate, B.P. |
|
58 | “DIGESTELACT”............... | With the written authority of the Secretary—Lactose intolerance |
59 | Dihydrotachysterol, B.P............ | With the written authority of the Secretary— |
|
| Hypoparathyroidism |
|
| Osteomalacia following gastrectomy, severe steatorrhoea or renal failure |
|
| Vitamin D-resistant rickets |
60 | Diltiazem Hydrochloride........... | Angina where treatment with verapamil hydrochloride or nifedipine has failed |
61 | Dimethicones, B.P., Aerosol Spray.... | Ileostomy or colostomy conditions |
62 | Dimethicones, B.P., Creams......... | Any disease or condition in a paraplegic or quadriplegic patient |
|
| Ileostomy or colostomy conditions |
|
| Use with surgical applicances |
63 | Dioctyl Sodium Sulphosuccinate with Bisacodyl, B.P. | Any disease or condition in a paraplegic or quadriplegic patient |
|
| For use by patients who are receiving long-term extensive nursing care in hospitals or nursing homes |
|
| For use by patients for whose care a Commonwealth Domiciliary Nursing Care Benefit is approved |
64 | Dipyridamole Tablets, B.P........... | With the written authority of the Secretary |
|
| Biopsy proven glomerulonephritis |
|
| Mesangiocapillary renal disease |
|
| Renal allograft |
|
| Patients with cardiac valve prosthesis |
65 | Doxorubicin Hydrochloride......... | Acute leukaemia |
|
| Breast cancer |
|
| Endometrial carcinoma |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Classes of persons, diseases, &c., purposes and conditions specified in relation to the pharmaceutical benefit |
|
| Ewing’s sarcoma |
|
| Gastric cancer |
|
| Hepatoma |
|
| Intravesicular use in bladder cancer |
|
| Lymphoma |
|
| Multiple myeloma |
|
| Neuroblastoma |
|
| Osteosarcoma |
|
| Ovarian cancer |
|
| Soft tissue sarcoma |
|
| Thyroid cancer |
|
| Wilms’ tumour |
66 | (1) Doxycycline Hydrochloride, B.P., Capsules, 50 mg (base) (containing enteric coated pellets) | Bronchiectasis in patients over the age of 8 years |
| (2) Doxycycline Hydrochloride, B.P., Tablets, 50 mg (base) | Chronic bronchitis in patients over the age of 8 years |
|
| Severe acne |
67 | Dydrogesterone Tablets, B.P......... | With the written authority of the Secretary— Endometriosis, proven by visual means |
68 | Enalapril Maleate................ | Moderate or severe hypertension |
|
| For the continuing treatment of severe refractory cardiac failure where treatment with enalapril maleate was initiated in a hospital (in-patient or out-patient) |
69 | Ergocalciferol, B.P................ | Hypocalcaemia |
|
| Hypoparathyroidism |
|
| Osteomalacia following gastrectomy, severe steatorrhoea or renal failure |
|
| Vitamin D-resistant rickets |
70 | Ethacrynic Acid Tablets, B.P......... | Patients who are hypersensitive to other oral diuretics |
71 | Ethyloestrenol Tablets, B.P.......... | With the written authority of the Secretary— |
|
| Osteoporosis |
|
| Patients on long-term treatment with corticosteroids |
72 | Etretinate | With the written authority of the Secretary— |
|
| Treatment initiated in a hospital (in-patient or out-patient) of— |
|
| Chronic disfiguring discoid lupus erythematosus |
|
| Darier’s disease |
|
| Erythrokeratoderma |
|
| Pityriasis rubra pilaris |
|
| Severe congenital ichthyosis (lamellar, bullous and sex linked) |
|
| Severe intractable psoriasis |
|
| Severe palmo-plantar keratoderma |
|
| For the continuing treatment of a patient who has already received, for more than 6 months, therapy with etretinate for a condition listed above |
73 | Flecainide Acetate............... | For the continuing treatment of cardiac arrhythmias where treatment with flecainide acetate was initiated in a hospital (in-patient or outpatient) |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Classes of persons, diseases, &c., purposes and conditions specified in relation to the pharmaceutical benefit |
74 | (1) Flucloxacillin Capsules, B.P. | Infections due to the presence of penicillin-resistant staphylococci |
| (2) Flucloxacillin Sodium, B.P., with Purified Water, B.P. |
|
|
| Osteomyelitis |
75 | Flucytosine Tablets, B.P............ | Invasive or systemic fungal infections such as candidiasis, cryptococcosis and chromoblastomycosis |
76 | Fluoxymesterone Tablets, B.P........ | With the written authority of the Secretary— |
|
| Aplastic anaemias, proven |
|
| Carcinoma of the breast |
|
| Hypogonadism |
|
| Osteoporosis |
77 | (1) Fluphenazine Decanoate Injection, B.P. | Chorea |
|
| Hyperactive states of organic or toxic delirium |
| (2) Fluphenazine Hydrochloride, B.P. | Major psychoses including— |
| (3) Fluphenazine Tablets, B.P. | Major organic psychoses including arteriopathic dementia |
|
| Manic depressive disorder—manic phase |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
78 | Fosfestrol Sodium, B.P............. | Carcinoma of the prostate |
79 | Frusemide Tablets, B.P., 500 mg...... | Renal failure |
80 | Fusidic Acid, B.P................. | For use in combination with another antibiotic in the treatment of serious staphylococcal infections confirmed by bacteriological evidence |
81 | “GALACTOMIN, FORMULA No. 17” | With the written authority of the Secretary— Galactosaemia |
|
| Conditions needing an extreme restriction of lactose in the diet of a patient under the age of 4 years |
82 | “GALACTOMIN, FORMULA No. 19” | With the written authority of the Secretary— Glucose-galactose malabsorption |
83 | “GLUCOSE NUTRAMIGEN” | With the written authority of the Secretary— |
|
| Cows’ milk allergy in children under the age of 2 years |
|
| Cystic fibrosis (mucoviscidosis) |
|
| Galactosaemia |
|
| Glycogen storage disease due to glucose-6-phosphatase deficiency in children under the age of 2 years |
|
| Lactose intolerance |
84 | Griseofulvin Tablets, B.P........... | Recalcitrant tinea infections |
|
| Kerion |
85 | (1) Haloperidol, B.P. | Chorea |
| (2) Haloperidol Tablets, B.P. | Hyperactive states of organic or toxic delirium Major psychoses including— |
|
| Major organic psychoses including arteriopathic dementia |
|
| Manic depressive disorder—manic phase |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Classes of persons, diseases, &c., purposes and conditions specified in relation to the pharmaceutical benefit |
86 | Hydrocortisone Acetate, B.P., Rectal Foam | Proctitis |
|
| Ulcerative colitis |
87 | Hydrocortisone Acetate Injection, B.P. | Alopecia areata |
|
| For local intra-articular or peri-articular infiltration |
|
| Granulomata, dermal |
|
| Keloid |
|
| Lichen planus hypertrophic |
|
| Lichen simplex chronicus |
|
| Lupus erythematosus, chronic discoid |
88 | Hydrocortisone Sodium Succinate, B.P., Injection, 500 mg | Any disease or condition in a patient receiving treatment in a hospital |
89 | “INFASOY”................... | With the written authority of the Secretary— |
|
| Cows’ milk allergy in children under the age of 2 years |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
90 | Influenza Vaccine (Split Virion), Inactivated, B.P. | For prophylaxis of persons at special risk of adverse consequences from infections of the lower respiratory tract |
91 | (1) Insulin, Human (Synthetic) (2) Insulin Isophane, Human (Synthetic) | Diabetics exhibiting lipoatrophy, lipohypertrophy, local allergy or immunologic resistance |
|
| Newly diagnosed insulin dependent diabetics |
92 | “ISOMIL”..................... | With the written authority of the Secretary— |
|
| Cows’ milk allergy in children under the age of 2 years |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
93 | Isopropyl Monoester Polymer with Isopropyl Alcohol, B.P. | Ileostomy or colostomy conditions |
94 | Isotretinoin.................... | With the written authority of the Secretary— |
|
| Severe cystic acne not responsive to other therapy |
95 | (1) “KETOVITE” Liquid | With the written authority of the Secretary— |
| (2) “KETOVITE” Tablets | Chronic cholestasis |
|
| Galactosaemia |
|
| Persistent monosaccharide intolerance |
|
| Phenylketonuria |
|
| Tyrosinosis (hereditary) |
|
| Use in association with a ketogenic diet |
96 | Lactulose Solution, B.P............. | With the written authority of the Secretary— |
|
| Hepatic coma or pre-coma (chronic portosystemic encephalopathy) |
|
| Terminal malignant neoplasia |
97 | Leuprorelin Acetate.............. | With the written authority of the Secretary— Advanced cancer of the prostate |
98 | “LOCASOL”................... | With the written authority of the Secretary— |
|
| Hypercalcaemia in children under the age of 2 years |
|
| Osteopetrosis |
99 | “LOFENALAC” | Phenylketonuria |
100 | “MAXAMAID XP” | Phenylketonuria |
101 | (1) Medroxyprogesterone Acetate, B.P., Injection, 50 mg in 1 mL | Breast cancer |
| Endometrial cancer | |
|
| Renal cell cancer |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Classes of persons, diseases, &c., purposes and conditions specified in relation to the pharmaceutical benefit |
| (2) Medroxyprogesterone Acetate, B.P., Injection, 500 mg in 2.5 mL |
|
| (3) Medroxyprogesterone Acetate, B.P., Tablets, 100mg |
|
102 | Medroxyprogesterone Acetate, B.P., Injection, 150 mg in 1 mL | Breast cancer |
|
| Endometrial cancer |
|
| Precocious puberty |
|
| Renal cell cancer |
103 | Medroxyprogesterone Acetate, B.P., Tablets, 10 mg | Breast cancer |
| Dysfunctional uterine bleeding | |
|
| Endometrial cancer |
|
| Endometriosis |
|
| Precocious puberty |
|
| Renal cell cancer |
|
| Turner’s syndrome |
104 | Medroxyprogesterone Acetate, B.P., Tablets, 500 mg | Advanced breast cancer |
105 | Mefenamic Acid Capsules, B.P. | Dysmenorrhoea |
|
| Menorrhagia |
106 | (1) Methadone Injection, B.P. | Severe disabling pain not responding to non-narcotic analgesics |
| (2) Methadone Tablets, B.P. |
|
107 | Methenolone Acetate.............. | With the written authority of the Secretary— |
|
| Osteoporosis |
|
| Patients on long-term treatment with corticosteroids |
108 | Methylphenobarbitone, B.P.......... | Epilepsy |
109 | Methylprednisolone Acetate Injection, B.P. | For local intra-articular or peri-articular infiltration |
110 | Methyltestosterone Tablets, B.P., 5 mg | Hypogonadism in patients under the age of 16 years |
111 | Methyltestosterone Tablets, B.P., 25 mg or 50 mg | Carcinoma of the breast |
|
| Hypogonadism |
|
| Klinefelter’s syndrome (seminiferous tubule dysgenesis) |
112 | Metronidazole, B.P............... | Prophylaxis in large bowel surgery Treatment in a hospital of acute anaerobic sepsis |
113 | Mianserin Hydrochloride Tablets, B.P. | With the written authority of the Secretary— |
|
| Depressive illness in persons with cardiovascular disease or bladder neck obstruction |
114 | Minoxidil..................... | With the written authority of the Secretary— |
|
| For the continuing treatment of severe refractory hypertensive disease where treatment with minoxidil was initiated in a hospital (inpatient or out-patient) |
|
| For the continuing treatment of a patient who has already received, for more than 6 months, therapy with minoxidil for severe refractory hypertension |
115 | Misoprostol.................... | With the written authority of the Secretary— |
|
| Duodenal ulcer (including pyloric ulcer), confirmed by radiology, endoscopy or surgery |
|
| Gastric ulcer, confirmed by radiology, endoscopy or surgery |
116 | Mithramycin................... | For use in a hospital for— |
|
| Inoperable testicular neoplasm |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Classes of persons, diseases, &c., purposes and conditions specified in relation to the pharmaceutical benefit |
|
| Symptomatic hypercalcaemia and hypercalcinuria associated with advanced neoplasia |
117 | Morphine Sulphate, B.P., with Tacrine Hydrochloride | Severe intractable pain |
118 | (1) Nalidixic Acid Mixture, B.P. | For use as a urinary antiseptic in patients with neurogenic bladder |
| (2) Nalidixic Acid Tablets, B.P. |
|
|
| Urinary tract infections where current clinical and bacteriological evidence confirm that nalidixic acid is an appropriate therapeutic agent |
119 | (1) Nandrolone Decanoate Injection, B.P. | With the written authority of the Secretary— |
|
| Carcinoma of the breast |
| (2) Nandrolone Phenylpropionate Injection, B.P. | Osteoporosis |
|
| Patients on long-term treatment with corticosteroids |
120 | Neomycin Tablets, B.P............. | Acute leukaemia during induction of remission with chemotherapy |
|
| Bowel sterilisation preparatory to major surgery |
|
| Encephalopathy, hepatic |
121 | Norethisterone Acetate, B.P., Tablets, 10 mg | Malignant neoplasia |
122 | “ODORTROL”................. | Ileostomy or colostomy conditions |
123 | Orphenadrine Hydrochloride Tablets, B.P. | Parkinsonism |
124 | (1) Oxycodone Hydrochloride | Severe disabling pain not responding to non-narcotic analgesics |
| (2) Oxycodone Pectinate |
|
125 | Oxymetholone Tablets, B.P.......... | With the written authority of the Secretary — |
|
| Proven aplastic anaemias |
|
| Myelosclerosis |
126 | (1) Pancreatin, B.P. | Cystic fibrosis (mucoviscidosis) |
| (2) Pancrelipase | Following pancreatico-duodenectomy |
|
| Pancreatic steatorrhoea |
127 | Papaveretum, Tablets............. | Disabling pain associated with proven malignant neoplasia |
|
| Disabling pain of short duration not responding to non-narcotic analgesics, the maximum duration of treatment being two weeks |
128 | (1) Penicillamine, B.P. | Acute heavy metal intoxication |
| (2) Penicillamine Tablets, B.P. | Cystinosis |
|
| Cystinuria with calculus formation |
|
| Haemoglobinuria, paroxysmal cold |
|
| Severe rheumatoid arthritis |
|
| Wilson’s disease (hepatolenticular degeneration) |
129 | Perhexiline Maleate | With the written authority of the Secretary— Angina not responding to other therapy |
130 | Pericyazine.................... | Chorea |
|
| Hyperactive states of organic or toxic delirium Major psychoses including— |
|
| Major organic psychoses including arteriopathic dementia |
|
| Manic depressive disorder—manic phase |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Severe conduct disorders in patients under the age of 16 years |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Classes of persons, diseases, &c., purposes and conditions specified in relation to the pharmaceutical benefit |
131 | Pethidine Tablets, B.P............. | With the written authority of the Secretary— |
|
| Disabling pain associated with proven malignant neoplasia |
132 | Phenelzine Tablets, B.P............ | Depressive illness resistant to treatment with either tricyclic antidepressants or electroconvulsive therapy |
|
| Phobic states |
133 | (1) Phenobarbitone, B.P. | Epilepsy |
| (2) Phenobarbitone Injection, B.P. |
|
| (3) Phenobarbitone Sodium, B.P. |
|
| (4) Phenobarbitone Tablets, B.P. |
|
134 | Phenoxybenzamine Capsules, B.P. | With the written authority of the Secretary— |
|
| Neurogenic urinary retention |
|
| Phaeochromocytoma |
135 | Pilocarpine.................... | With the written authority of the Secretary— |
|
| Chronic glaucoma when other miotics are not tolerated |
136 | (1) “PK AID I” | Phenylketonuria |
| (2) “PK AID II” |
|
137 | Pneumococcal Vaccine, Polyvalent | Splenectomised persons over the age of 2 years |
|
| Persons with Hodgkin’s disease |
|
| Persons at high risk of pneumococcal infections |
138 | Polyestradiol Phosphate............ | Carcinoma of the breast |
|
| Carcinoma of the prostate |
139 | Polyisobutylene................. | Ileostomy or colostomy conditions |
140 | Polyvinylpyrrolidone and Vinyl Acetate Copolymer | Ileostomy or colostomy conditions |
|
|
|
141 | “PORTAGEN”................. | With the written authority of the Secretary— |
|
| Patients requiring a ketogenic diet for intractable childhood epilepsy |
|
| Proven malabsorption |
142 | Prednisolone Acetate, Injection | For local intra-articular or peri-articular infiltration |
143 | Prednisolone Acetate with Phenylephrine Hydrochloride, B.P. | Corneal grafts |
|
| Uveitis |
144 | Prednisolone Sodium Phosphate, B.P., Retention Enema and Suppositories | Ulcerative colitis |
|
| Proctitis |
145 | “PREGESTIMIL”............... | With the written authority of the Secretary— |
|
| Biliary atresia |
|
| Cystic fibrosis |
|
| Enterokinase deficiency |
|
| Intolerance to both milk protein and soya protein |
|
| Severe diarrhoea of greater than two weeks duration in infants under the age of 4 months |
146 | Probucol...................... | With the written authority of the Secretary— |
|
| Familial hypercholesterolaemia inadequately responsive to diet and a course of cholesterol lowering resin |
147 | Propantheline Tablets, B.P........... | Chronic neurogenic incontinence of urine |
148 | “PROSOBEE”.................. | With the written authority of the Secretary— |
|
| Cows’ milk allergy in children under the age of 2 years |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Classes of persons, diseases, &c., purposes and conditions specified in relation to the pharmaceutical benefit |
149 | Pyridoxine Hydrochloride Tablets, B.P. | Anaemia proved to be responsive to pyridoxine |
|
| Convulsions responsive to pyridoxine |
|
| Homocystinuria |
|
| Primary hyperoxaluria |
|
| Radiation sickness |
|
| Sideroblastic (refractory) anaemia |
|
| Treatment and prophylaxis of peripheral neuritis caused or likely to be caused by isoniazid therapy |
150 | Ranitidine Hydrochloride........... | With the written authority of the Secretary— |
|
| Duodenal ulcer (including pyloric ulcer), confirmed by radiology, endoscopy or surgery |
|
| Gastric ulcer, confirmed by radiology, endoscopy or surgery |
|
| Severe ulcerating (erosive) oesophagitis, confirmed by endoscopy |
|
| Ulcerating (erosive) oesophagitis in scleroderma |
|
| Zollinger-Ellison syndrome, proven by investigation |
151 | Rifampicin, B.P.................. | Prophylaxis of meningococcal disease in close contacts and carriers |
|
| With the written authority of the Secretary— Leprosy in adults |
152 | Silver Sulphadiazine with Chlorhexidine Gluconate Cream | With the written authority of the Secretary— Treatment, in a hospital of burns |
153 | Sodium Acid Phosphate, B.P., Compound Effervescent Tablets | With the written authority of the Secretary— Familial hypophosphataemia |
|
| Hypercalcaemia |
|
| Hypophosphataemic rickets |
|
| Vitamin D-resistant rickets |
154 | Sodium Cromoglycate, B.P., Eye Drops | With the written authority of the Secretary— |
|
| Vernal kerato-conjunctivitis |
155 | Sodium Cromoglycate, B.P., Nebuliser Solution | Use in a power-operated nebuliser for prophylaxis of asthma in persons who are unable to use the capsule or metered aerosol spray for oral inhalation |
156 | Sodium Cromoglycate, B.P., Eye Drops | For use in combination with another antibiotic in the treatment of serious staphylococcal infections confirmed by bacteriological evidence |
157 | Spironolactone Tablets, B.P.......... | Hyperaldosteronism |
158 | Sterculia, B.P................... | Ileostomy or colostomy conditions |
159 | Sucralfate..................... | With the written authority of the Secretary— |
|
| Duodenal ulcer (including pyloric ulcer), confirmed by radiology, endoscopy or surgery |
|
| Gastric ulcer, confirmed by radiology, endoscopy or surgery |
160 | Sulindac Tablets, B.P.............. | Osteoarthritis |
|
| Rheumatoid arthritis |
161 | Sulphasalazine.................. | Crohn’s disease |
|
| Ulcerative colitis |
162 | Sulphinpyrazone Tablets, B.P......... | With the written authority of the Secretary — |
|
| Glomerulonephritis |
|
| Gout |
|
| Renal transplantation |
163 | (1) Surgical Cement (2) Surgical Cement Solvent | Any disease or condition in a paraplegic or quadriplegic patient |
|
| For use with surgical appliances |
|
| Ileostomy or colostomy conditions |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Classes of persons, diseases, &c., purposes and conditions specified in relation to the pharmaceutical benefit |
164 | Tamoxifen Citrate Tablets, B.P. | Recurrent or metastatic breast cancer |
165 | (1) Testosterone Enanthate, B.P. | Carcinoma of the breast |
| (2) Testosterone Propionate Injection, B.P. | Hypogonadism |
|
| Klinefelter’s syndrome (seminiferous tubule dysgenesis) |
166 | (1) Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., and Testosterone Isocaproate, B.P. | Carcinoma of the breast |
|
| Gigantism |
|
| Hypogonadism |
|
| Klinefelter’s syndrome (seminiferous tubule dysgenesis) |
| (2) Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate, B.P., and Testosterone Decanoate, B.P. |
|
167 | Tetrabenazine.................. | Chorea not adequately controlled by other drug therapy |
168 | Tetracosactrin Zinc Injection, B.P. | With the written authority of the Secretary— |
|
| Hypsarrhythmia |
|
| Multiple sclerosis, acute exacerbation |
|
| Treatment of children who need long-term corticosteroid therapy but who are in danger of growth suppression as a result |
|
| Treatment of patients who are being withdrawn from long-term corticosteroid therapy |
|
| Ulcerative colitis, proven, not responding to parenteral corticostereoids |
169 | Thiopropazate Hydrochloride Tablets, B.P. | Chorea |
170 | (1) Thioridazine Hydrochloride, B.P. | Chorea |
|
| Hyperactive states of organic or toxic delirium |
| (2) Thioridazine Tablets, B.P. | Major psychoses including— |
|
| Major organic psychoses including arteriopathic dementia |
|
| Manic depressive disorder—manic phase |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Severe conduct disorders in patients under the age of 16 years |
171 | Ticarcillin Sodium............... | With the written authority of the Secretary— |
|
| Infections where positive bacteriological evidence confirms that ticarcillin sodium is an appropriate therapeutic agent |
|
| Septicaemia, suspected or proven |
172 | Tobramycin Injection, B.P........... | Infections where positive bacteriological evidence confirms that tobramycin is an appropriate antibiotic |
|
| Septicaemia, suspected or proven |
173 | Tranexamic Acid Tablets, B.P........ | Hereditary angio-oedema |
174 | Tranylcypromine Tablets, B.P........ | Depressive illness resistant to treatment with either tricyclic antidepressants or electroconvulsive therapy |
|
| Phobic states |
SCHEDULE 5—continued
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Classes of persons, diseases, &c., purposes and conditions specified in relation to the pharmaceutical benefit |
175 | Triamcinolone Acetonide, B.P., Injection | Alopecia areata |
|
| For local intra-articular or peri-articular infiltration |
|
| Granulomata, dermal |
|
| Keloid |
|
| Lichen planus hypertrophic |
|
| Lichen simplex chronicus |
|
| Lupus erythematosus, chronic discoid |
|
| Necrobiosis lipoidica |
|
| Psoriasis |
176 | (1) Trifluoperazine Hydrochloride, B.P. | Chorea |
|
| Hyperactive states of organic or toxic delirium |
| (2) Trifluoperazine Hydrochloride Tablets, B.P. | Major psychoses including— |
|
| Major organic psychoses including arteriopathic dementia |
|
| Manic depressive disorder—manic phase |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Severe conduct disorders in patients under the age of 16 years |
177 | Triglycerides Oil, Medium Chain | With the written authority of the Secretary— |
|
| Abetalipoproteinaemia |
|
| Intestinal lymphangiectasia |
|
| Intractable childhood epilepsy requiring a ketogenic diet |
|
| Short-term nutritional support in severe steatorrhoea |
|
| Steatorrhoea due to distal small bowel resection |
178 | Trimethoprim Tablets, B.P.......... | Acute urinary tract infections |
179 | Trioxysalen.................... | Vitiligo |
180 | Tri-potassium Di-citrato Bismuthate Complex | With the written authority of the Secretary— |
|
| Duodenal ulcer (including pyloric ulcer), confirmed by radiology, endoscopy or surgery |
|
| Gastric ulcer, confirmed by radiology, endoscopy or surgery |
181 | Vancomycin Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment in a hospital |
|
| Endophthalmitis |
182 | Vidarabine.................... | Eye infections caused by herpes simplex virus where idoxuridine has proved ineffective |
183 | “ZERODOR”.................. | Ileostomy or colostomy conditions |
184 | “ZOFF”...................... | Any disease or condition in a paraplegic or quadriplegic patient |
|
| For use with surgical appliances |
|
| Ileostomy or colostomy conditions |
NOTES
1. Notified in the Commonwealth of Australia Gazette on 31 July 1986.
2. Statutory Rules 1960 No. 17 as amended by 1960 Nos. 90 and 102; 1961 Nos. 59 and 137; 1962 Nos. 34, 101 and 114; 1963 Nos. 34, 69 and 107; 1964 Nos. 12, 57 and 135; 1965 Nos. 51, 151 and 152; 1966 Nos. 80 and 144; 1967 Nos. 67, 116 and 158; 1968 Nos. 44, 76, 88 and 146; 1969 Nos. 44, 107 and 185; 1970 Nos. 39, 94, 119 and 186; 1971 Nos. 44, 101, 136 and 154; 1972 Nos. 32, 121 and 205; 1973 Nos. 15, 57, 139 and 229; 1974 Nos. 37, 126 and 222; 1975 Nos. 50, 148 and 209; 1976 Nos. 84, 150, 195 and 255; 1977 Nos. 39, 125 and 221; 1978 Nos. 47, 142, 153 and 245; 1979 Nos. 51, 55, 144, and 250; 1980 Nos. 69, 213 and 338; 1981 Nos. 52, 212, 218 and 345; 1982 Nos. 69, 76, 179, 334 and 372; 1983 Nos. 28, 102, 116 and 292; 1984 Nos. 50, 148, 169 and 342; 1985 Nos. 32, 184 and 320; 1986 No. 38.
Printed by Authority by the Commonwealth Government Printer